A O
portion O
of O
Region O
II O
also O
resembles O
part O
of O
the O
human O
c B
- I
jun I
oncoprotein O
' O
s O
leucine O
zipper O
, O
which O
in O
turn O
, O
has O
been O
demonstrated O
to O
be O
the O
heterodimerization O
site O
between O
the O
jun B
and O
fos B
oncoproteins I
. O

Influence O
of O
cyclo B
- I
oxygenase I
inhibition O
and O
of O
leukotriene B
receptor I
blockade O
on O
pulmonary O
vascular O
pressure O
/ O
cardiac O
index O
relationships O
in O
hyperoxic O
and O
in O
hypoxic O
dogs O
. O

The O
HMG B
domain I
of O
both O
HMG20 B
proteins I
is O
most O
similar O
to O
that O
of O
yeast B
NHP6A I
( O
38 O
% O
to O
42 O
% O
) O
. O

The O
HMG B
domain I
of O
both O
HMG20 B
proteins I
is O
most O
similar O
to O
that O
of O
yeast B
NHP6A I
( O
38 O
% O
to O
42 O
% O
) O
. O

The O
HMG B
domain I
of O
both O
HMG20 B
proteins I
is O
most O
similar O
to O
that O
of O
yeast B
NHP6A I
( O
38 O
% O
to O
42 O
% O
) O
. O

Thus O
, O
an O
increase O
in O
plasma B
TBG I
and O
a O
shift O
from O
adrenal O
androgen O
and O
mineralocorticoid O
steroid O
secretion O
towards O
cortisol O
secretion O
may O
be O
endocrine O
markers O
for O
progression O
of O
the O
disease O
in O
patients O
with O
HIV O
- O
infection O
. O

Remarkably O
, O
U21 B
contains O
a O
long O
stretch O
( O
13 O
nt O
. O
) O
of O
complementarity O
to O
a O
highly O
conserved O
sequence O
in O
28S B
rRNA I
. O

Data O
from O
in O
vitro O
splicing O
assays O
, O
UV O
crosslinking O
and O
RNA O
- O
binding O
competition O
experiments O
indicates O
a O
strong O
correlation O
between O
the O
binding O
affinities O
of O
PSI B
for O
the O
SELEX O
sequences O
and O
their O
ability O
to O
modulate O
splicing O
of O
P B
element I
IVS3 B
in O
vitro O
. O

We O
have O
previously O
shown O
that O
the O
adenoviral B
12S I
E1A I
protein I
modulates O
the O
phosphorylation O
status O
of O
p130 B
and O
p107 B
without O
apparent O
changes O
in O
the O
cell O
cycle O
dependent O
phosphorylation O
of O
the O
retinoblastoma B
protein I
. O

In O
some O
early O
B O
cells O
and O
Abelson O
murine O
leukemia O
virus O
- O
transformed O
pre O
- O
B O
- O
cell O
lines O
, O
LT B
mRNA I
is O
constitutively O
expressed O
. O

The O
median O
post O
- O
treatment O
, O
pre O
- O
operative O
serum B
PSA I
was O
0 O
. O
4 O
ng O
/ O
ml O
. O

This O
finding O
is O
the O
first O
example O
of O
utilization O
of O
noncomplementary O
dinucleotide O
primer O
by O
an O
RNA B
polymerase I
. O

Mucin B
gene I
expression O
has O
been O
shown O
to O
be O
altered O
in O
many O
intestinal O
diseases O
and O
especially O
cancers O
of O
the O
gastrointestinal O
tract O
. O

In O
both O
cases O
, O
at O
the O
end O
of O
exposure O
the O
same O
level O
of O
blood B
carboxyhemoglobin I
( O
COHb B
) O
( O
about O
50 O
% O
) O
was O
reached O
. O

Weak O
promoter O
activity O
was O
observed O
for O
the O
promoter O
of O
the O
C1 B
and O
C2 B
ORFs O
( O
C1 B
- O
C2 B
gene O
) O
and O
for O
the O
promoter O
of O
the O
V1 B
ORF I
. O

Acute O
idiopathic O
thrombocytopenic O
purpura O
presenting O
a O
high O
serum O
level O
of O
immunoglobulin B
E I
and O
eosinophilia O
in O
an O
elderly O
patient O
. O

Thus O
, O
elongin B
C I
is O
found O
to O
oligomerize O
in O
solution O
and O
to O
undergo O
significant O
structural O
rearrangements O
upon O
binding O
of O
two O
different O
partner O
proteins O
. O

Targeted O
disruption O
of O
the O
OGG1 B
gene I
in O
yeast O
revealed O
a O
second O
OG B
glycosylase I
/ I
lyase I
protein I
, O
tentatively O
named O
Ogg2 B
, O
which O
differs O
from O
Ogg1 B
in O
that O
it O
preferentially O
acts O
on O
OG O
: O
G O
. O

Using O
mouse O
- O
human O
somatic O
hybrids O
and O
FISH O
analysis O
, O
the O
PE B
- I
2 I
gene I
is O
localized O
to O
human O
chromosome O
19q13 O
. O
2 O
, O
a O
region O
involved O
in O
translocations O
and O
deletions O
in O
leukemias O
and O
several O
solid O
tumors O
, O
suggesting O
that O
this O
novel O
ETS B
factor I
may O
play O
a O
role O
in O
carcinogenesis O
. O

Using O
sequence O
information O
from O
human B
BMAL1 I
( O
hBMAL1 B
) O
cDNAs O
previously O
reported O
by O
our O
laboratory O
, O
we O
have O
isolated O
and O
characterized O
cDNAs O
encoding O
three O
splice O
variants O
of O
the O
mouse B
BMAL1 I
( O
mBMAL1 B
) O
gene O
. O

Using O
sequence O
information O
from O
human B
BMAL1 I
( O
hBMAL1 B
) O
cDNAs O
previously O
reported O
by O
our O
laboratory O
, O
we O
have O
isolated O
and O
characterized O
cDNAs O
encoding O
three O
splice O
variants O
of O
the O
mouse B
BMAL1 I
( O
mBMAL1 B
) O
gene O
. O

The O
atp B
1 I
and O
atp B
2 I
types O
of O
cDNA O
sequences O
were O
the O
most O
redundant O
among O
the O
28 O
different O
isoperoxidases B
identified O
among O
about O
200 O
peroxidase B
encoding I
ESTs I
. O

The O
atp B
1 I
and O
atp B
2 I
types O
of O
cDNA O
sequences O
were O
the O
most O
redundant O
among O
the O
28 O
different O
isoperoxidases B
identified O
among O
about O
200 O
peroxidase B
encoding I
ESTs I
. O

In O
patients O
with O
type O
IA O
maple O
syrup O
urine O
disease O
, O
the O
E1alpha B
subunit I
is O
affected O
, O
resulting O
in O
the O
loss O
of O
E1 B
and O
branched B
- I
chain I
ketoacid I
dehydrogenase I
catalytic O
activities O
. O

RNA O
blot O
hybridizations O
identified O
an O
1 O
. O
8 O
- O
kb O
mRNA O
common O
to O
cytochrome B
b6 I
and O
subunit O
IV O
, O
and O
an O
intensely O
hybridizing O
0 O
. O
8 O
- O
kb O
mRNA O
specific O
to O
the O
subunit O
IV O
gene O
probe O
. O

We O
have O
demonstrated O
that O
the O
activity O
of O
ILK B
is O
constitutively O
elevated O
in O
PTEN B
mutant I
cells O
. O

The O
galactose B
transporter I
shows O
both O
sequence O
and O
structural O
homology O
with O
a O
superfamily O
of O
sugar B
transporters I
which O
includes O
the O
human B
HepG2 I
- I
erythrocyte I
and I
fetal I
muscle I
glucose I
transporters I
, O
the O
rat B
brain I
and I
liver I
glucose I
transporters I
, O
the O
Escherichia B
coli I
xylose I
and I
arabinose I
permeases I
, O
and O
the O
S B
. I
cerevisiae I
glucose I
, I
maltose I
, I
and I
galactose I
transporters I
. O

The O
galactose B
transporter I
shows O
both O
sequence O
and O
structural O
homology O
with O
a O
superfamily O
of O
sugar B
transporters I
which O
includes O
the O
human B
HepG2 I
- I
erythrocyte I
and I
fetal I
muscle I
glucose I
transporters I
, O
the O
rat B
brain I
and I
liver I
glucose I
transporters I
, O
the O
Escherichia B
coli I
xylose I
and I
arabinose I
permeases I
, O
and O
the O
S B
. I
cerevisiae I
glucose I
, I
maltose I
, I
and I
galactose I
transporters I
. O

Although O
the O
OC B
promoter I
is O
activated O
in O
a O
C O
terminus O
dependent O
manner O
, O
the O
MDR B
, O
LTR O
and O
BSP B
promoters I
are O
repressed O
by O
three O
distinct O
mechanisms O
, O
either O
independent O
of O
or O
involving O
the O
AML B
C I
terminus I
, O
or O
requiring O
only O
the O
conserved O
C O
- O
terminal O
pentapeptide O
VWRPY O
. O

Although O
the O
OC B
promoter I
is O
activated O
in O
a O
C O
terminus O
dependent O
manner O
, O
the O
MDR B
, O
LTR O
and O
BSP B
promoters I
are O
repressed O
by O
three O
distinct O
mechanisms O
, O
either O
independent O
of O
or O
involving O
the O
AML B
C I
terminus I
, O
or O
requiring O
only O
the O
conserved O
C O
- O
terminal O
pentapeptide O
VWRPY O
. O

The O
COOH O
- O
terminal O
region O
of O
the O
transcripts O
contained O
fifteen O
triplet O
repeats O
( O
GCT O
; O
alanine O
) O
at O
nucleotide O
465 O
to O
509 O
, O
which O
is O
significantly O
expanded O
compared O
to O
the O
rat B
RL14 I
. O

Both O
toxins O
in O
a O
dose O
10 O
- O
fold O
surpassing O
the O
maximum O
permissible O
concentration O
increased O
activity O
of O
glutathione B
peroxidase I
in O
brain O
tissue O
; O
moreover O
, O
toluene O
increased O
chemiluminescence O
intensity O
, O
which O
attested O
to O
activation O
of O
free O
radical O
processes O
. O

Several O
7SL B
RNA I
- I
encoding I
sequences I
and O
various O
intergenic O
spacers O
were O
amplified O
from O
the O
individual O
HindIII B
fragments I
of O
about O
1 O
. O
3 O
and O
2 O
. O
8 O
kb O
. O

The O
two O
IL6 B
mRNA I
species O
are O
generated O
by O
alternative O
polyadenylation O
at O
sites O
separated O
by O
a O
distance O
of O
1 O
. O
2 O
kilobases O
. O

In O
the O
last O
20 O
years O
, O
the O
therapeutic O
uses O
of O
botulinum B
toxin I
, O
a O
potent O
neurotoxin O
, O
have O
been O
investigated O
. O

AgMNPV O
and O
Orgyia O
pseudotsugata O
MNPV O
( O
OpMNPV O
) O
are O
similar O
in O
terms O
of O
promoter O
structure O
and O
polyhedrin B
primary I
sequence I
, O
and O
the O
polyhedrin B
gene I
of O
both O
viruses O
is O
transcribed O
in O
the O
anti O
- O
clockwise O
direction O
in O
relation O
to O
their O
physical O
maps O
. O

Thus O
E14 O
. O
1TG3B1 O
is O
a O
useful O
ES O
cell O
line O
for O
modifying O
the O
mouse O
genome O
using O
the O
HPRT B
gene I
as O
a O
selection O
marker O
and O
for O
transmission O
at O
a O
high O
frequency O
into O
the O
mouse O
germ O
line O
. O

Recent O
studies O
have O
revealed O
unconventional O
myosin B
V I
to O
be O
an O
important O
actin B
- O
based O
molecular O
motor O
involved O
in O
vesicular O
movement O
. O

The O
pheromone O
response O
pathway O
activates O
transcription O
of O
Ty5 B
retrotransposons I
located O
within O
silent O
chromatin O
of O
Saccharomyces O
cerevisiae O
. O

In O
the O
budding O
yeast O
, O
Saccharomyces O
cerevisiae O
, O
replicators O
can O
function O
outside O
the O
chromosome O
as O
autonomously O
replicating O
sequence O
( O
ARS O
) O
elements O
; O
however O
, O
within O
chromosome O
III O
, O
certain O
ARSs O
near O
the O
transcriptionally O
silent O
HML B
locus I
show O
no O
replication O
origin O
activity O
. O

The O
leader O
sequence O
of O
the O
isolated O
cDNA O
clone O
contains O
several O
small O
open O
reading O
frames O
upstream O
of O
the O
initiation O
codon O
of O
the O
largest O
open O
reading O
frame O
coding O
for O
the O
homeodomain B
protein I
. O

We O
mapped O
the O
DGCR6 B
gene I
to O
chromosome O
22q11 O
within O
a O
low O
copy O
repeat O
, O
termed O
sc11 O
. O
1a O
, O
and O
identified O
a O
second O
copy O
of O
the O
gene O
, O
DGCR6L B
, O
within O
the O
duplicate O
locus O
, O
termed O
sc11 O
. O
1b O
. O

Attenuation O
from O
the O
vit B
A2 I
consensus O
ERE O
is O
not O
necessarily O
dependent O
on O
DNA O
binding O
as O
the O
TR B
alpha I
DNA O
binding O
mutant O
was O
still O
able O
to O
inhibit O
E O
- O
dependent O
transactivation O
. O

Attenuation O
from O
the O
vit B
A2 I
consensus O
ERE O
is O
not O
necessarily O
dependent O
on O
DNA O
binding O
as O
the O
TR B
alpha I
DNA O
binding O
mutant O
was O
still O
able O
to O
inhibit O
E O
- O
dependent O
transactivation O
. O

Glomerular O
mesangial O
cells O
expressed O
an O
abundant O
1 O
. O
1 O
kb O
mRNA O
transcript O
for O
Id1 B
, O
but O
in O
contrast O
to O
other O
cell O
types O
Id1 B
mRNA I
was O
expressed O
in O
both O
randomly O
cycling O
cells O
and O
in O
serum O
- O
deprived O
, O
quiescent O
cultures O
. O

There O
was O
no O
apparent O
effect O
of O
growth O
temperature O
on O
the O
steady O
- O
state O
levels O
of O
fad7 B
mRNA I
in O
wild O
type O
plants O
. O

We O
evaluated O
the O
likelihood O
of O
tissues O
to O
be O
positive O
for O
carcinoembryonic B
antigen I
and O
the O
intensity O
of O
carcinoembryonic B
antigen I
staining O
in O
specimens O
of O
villous O
adenomas O
, O
mixed O
polypoid O
villous O
adenomas O
, O
polypoid O
adenomas O
, O
and O
diverticulitis O
using O
the O
peroxidase B
- O
antiperoxidase B
technique O
. O

We O
evaluated O
the O
likelihood O
of O
tissues O
to O
be O
positive O
for O
carcinoembryonic B
antigen I
and O
the O
intensity O
of O
carcinoembryonic B
antigen I
staining O
in O
specimens O
of O
villous O
adenomas O
, O
mixed O
polypoid O
villous O
adenomas O
, O
polypoid O
adenomas O
, O
and O
diverticulitis O
using O
the O
peroxidase B
- O
antiperoxidase B
technique O
. O

Comparison O
with O
the O
sequence O
databanks O
show O
that O
Tactile B
is O
a O
member O
of O
the O
immunoglobulin B
gene I
superfamily I
, O
with O
similarity O
to O
Drosophila B
amalgam I
, O
the O
melanoma B
Ag I
MUC I
- I
18 I
, O
members O
of O
the O
carcinoembryonic B
Ag I
family I
, O
the O
poliovirus B
receptor I
, O
and O
the O
neural B
cell I
adhesion I
molecule I
. O

Comparison O
with O
the O
sequence O
databanks O
show O
that O
Tactile B
is O
a O
member O
of O
the O
immunoglobulin B
gene I
superfamily I
, O
with O
similarity O
to O
Drosophila B
amalgam I
, O
the O
melanoma B
Ag I
MUC I
- I
18 I
, O
members O
of O
the O
carcinoembryonic B
Ag I
family I
, O
the O
poliovirus B
receptor I
, O
and O
the O
neural B
cell I
adhesion I
molecule I
. O

A O
cis O
- O
acting O
DNA O
element O
located O
between O
TATA O
box O
and O
transcription O
initiation O
site O
is O
critical O
in O
response O
to O
regulatory O
sequences O
in O
human O
angiotensinogen B
gene I
. O

The O
primary O
structure O
and O
cotranscription O
of O
the O
petCA B
genes I
encoding O
the O
Rieske B
- I
FeS I
( O
nuclear B
encoded I
in I
plants I
) O
and O
apocytochrome B
f I
proteins I
has O
been O
described O
previously O
( O
Kallas O
, O
T O
. O
, O
Spiller O
, O
S O
. O
, O
and O
Malkin O
, O
R O
. O

One O
complex O
most O
likely O
contained O
Sp1 B
, O
and O
another O
complex O
showed O
S O
- O
phase O
- O
specific O
binding O
, O
suggesting O
a O
direct O
role O
in O
the O
cell O
- O
cycle O
- O
dependent O
R1 B
gene I
expression O
. O

We O
found O
that O
120 O
bp O
of O
the O
enhancer O
' O
s O
transcriptional O
core O
becomes O
DNase B
I I
hypersensitive O
early O
in O
B O
- O
cell O
development O
. O

Pokeweed B
antiviral I
protein I
( O
PAP B
) O
from O
Phytolacca O
americana O
is O
a O
highly O
specific O
N B
- I
glycosidase I
removing O
adenine O
residues O
( O
A4324 O
in O
28S B
rRNA I
and O
A2660 O
in O
23S B
rRNA I
) O
from O
intact O
ribosomes O
of O
both O
eukaryotes O
and O
prokaryotes O
. O

Pokeweed B
antiviral I
protein I
( O
PAP B
) O
from O
Phytolacca O
americana O
is O
a O
highly O
specific O
N B
- I
glycosidase I
removing O
adenine O
residues O
( O
A4324 O
in O
28S B
rRNA I
and O
A2660 O
in O
23S B
rRNA I
) O
from O
intact O
ribosomes O
of O
both O
eukaryotes O
and O
prokaryotes O
. O

Pseudosubstrate O
( O
19 O
- O
36 O
) O
, O
derived O
from O
the O
C O
- O
terminus O
of O
Ca B
- I
dependent I
PKC I
isotypes I
, O
inhibited O
beta B
- I
PKC I
but O
not O
nPKC B
activity O
using O
either O
Histone B
IIIS I
or O
peptide O
( O
19 O
- O
31 O
) O
as O
substrate O
. O

HeLa O
and O
Jurkat O
cell O
lines O
carrying O
the O
nef B
gene I
linked O
to O
the O
CMV O
promoter O
or O
the O
HIV B
- I
1 I
LTR I
were O
isolated O
by O
coselection O
for O
neomycin O
resistance O
. O

Serotonin B
receptors I
in O
suicide O
victims O
with O
major O
depression O
. O

Effects O
of O
methiothepin O
and O
lysergic O
acid O
diethylamide O
on O
serotonin O
release O
in O
vitro O
and O
serotonin O
synthesis O
in O
vivo O
: O
possible O
relation O
to O
serotonin B
autoreceptor I
function O
. O

Nucleotide O
sequences O
between O
the O
env B
gene I
and O
the O
LTR B
of I
SFV I
- I
1 I
were O
determined O
. O

Two O
separate O
NF1 B
- I
binding I
loci I
were O
also O
found O
in O
the O
equivalent O
IE68 B
gene I
of O
HCMV O
( O
Towne O
) O
DNA O
, O
but O
in O
this O
case O
the O
DNA O
sequence O
and O
competition O
filter O
binding O
experiments O
indicated O
a O
maximum O
of O
only O
four O
to O
five O
consensus O
binding O
sites O
encompassing O
the O
promoter O
- O
enhancer O
region O
. O

RT O
- O
PCR O
indicated O
that O
p21 B
mRNA I
was O
induced O
1 O
. O
4 O
- O
, O
2 O
. O
0 O
- O
, O
and O
3 O
. O
1 O
- O
fold O
in O
the O
2 O
- O
day O
neonatal O
, O
7 O
- O
day O
neonatal O
, O
and O
adult O
stages O
, O
respectively O
, O
compared O
to O
the O
17 O
- O
day O
fetal O
stage O
. O

The O
absolute O
concentrations O
of O
alpha B
2 I
- I
plasmin I
inhibitor O
, O
alpha B
2 I
- I
macroglobulin I
, O
and O
antithrombin B
III I
increased O
with O
exercise O
( O
all O
P O
less O
than O
0 O
. O
005 O
) O
, O
but O
when O
concentrations O
were O
corrected O
for O
acute O
shifts O
of O
plasma O
water O
during O
exercise O
, O
the O
quantity O
of O
these O
inhibitors O
actually O
decreased O
( O
all O
P O
less O
than O
0 O
. O
005 O
) O
. O

Members O
of O
the O
Ras B
subfamily I
of O
small B
GTP I
- I
binding I
proteins I
have O
been O
shown O
to O
be O
promiscuous O
towards O
a O
variety O
of O
putative O
effector O
molecules O
such O
as O
the O
protein B
kinase I
c I
- I
Raf I
and O
the O
Ral B
- I
specific I
guanine I
nucleotide I
exchange I
factor I
( O
Ral B
- I
GEF I
) O
. O

Almost O
complete O
sequence O
identity O
was O
found O
between O
the O
3 O
' O
end O
of O
the O
DXS6673E B
gene I
and O
two O
expressed O
sequence O
tags O
( O
ESTs O
) O
and O
between O
the O
5 O
' O
end O
of O
the O
DXS6673E B
gene I
and O
a O
third O
EST O
. O

Almost O
complete O
sequence O
identity O
was O
found O
between O
the O
3 O
' O
end O
of O
the O
DXS6673E B
gene I
and O
two O
expressed O
sequence O
tags O
( O
ESTs O
) O
and O
between O
the O
5 O
' O
end O
of O
the O
DXS6673E B
gene I
and O
a O
third O
EST O
. O

Transcriptional O
regulation O
of O
the O
GluR2 B
gene I
: O
neural O
- O
specific O
expression O
, O
multiple O
promoters O
, O
and O
regulatory O
elements O
. O

Serum B
TNF I
concentrations O
were O
elevated O
at O
diagnosis O
and O
gradually O
decreased O
toward O
the O
reference O
limits O
by O
week O
16 O
. O

Serial O
followup O
strength O
data O
for O
2 O
patients O
were O
compared O
to O
change O
in O
creatinine B
kinase I
( O
CK B
) O
levels O
. O

To O
determine O
the O
signal B
recognition I
particle I
( O
SRP B
) O
- O
SRP B
receptor I
( O
Srb B
) O
system O
in O
Bacillus O
subtilis O
( O
Bs O
) O
, O
we O
cloned O
the O
Bs B
srb I
gene I
, O
which O
encodes O
a O
homologue O
of O
the O
mammalian B
SRP I
receptor I
alpha I
- I
subunit I
[ O
Oguro O
et O
al O
. O
, O
DNA O
Res O
. O

Molecular O
cloning O
and O
characterization O
of O
a O
new O
member O
of O
the O
rat B
placental I
prolactin I
( O
PRL B
) O
family O
, O
PRL B
- O
like O
protein B
H I
. O

Promoter O
activity O
was O
high O
in O
cell O
lines O
that O
expressed O
high O
levels O
of O
endogenous O
D3 B
mRNA I
, O
as O
indicated O
by O
Northern O
blot O
analyses O
, O
and O
was O
significantly O
reduced O
when O
the O
promoter O
was O
truncated O
to O
- O
122 O
bp O
. O

WRN B
helicase I
resolves O
alternate O
DNA O
structures O
including O
tetraplex O
and O
triplex O
DNA O
, O
and O
Holliday O
junctions O
. O

Transformation O
of O
the O
sconC3 B
mutant I
with O
sconB B
+ I
restores O
the O
wild O
- O
type O
phenotype O
. O

Transformation O
of O
the O
sconC3 B
mutant I
with O
sconB B
+ I
restores O
the O
wild O
- O
type O
phenotype O
. O

Molecular O
cloning O
and O
sequencing O
of O
a O
cDNA O
encoding O
SR B
beta I
revealed O
that O
SR B
beta I
is O
a O
transmembrane O
protein O
and O
, O
like O
SR B
alpha I
and O
SRP54 B
, O
is O
a O
member O
of O
the O
GTPase B
superfamily I
. O

Molecular O
cloning O
and O
sequencing O
of O
a O
cDNA O
encoding O
SR B
beta I
revealed O
that O
SR B
beta I
is O
a O
transmembrane O
protein O
and O
, O
like O
SR B
alpha I
and O
SRP54 B
, O
is O
a O
member O
of O
the O
GTPase B
superfamily I
. O

Molecular O
cloning O
and O
sequencing O
of O
a O
cDNA O
encoding O
SR B
beta I
revealed O
that O
SR B
beta I
is O
a O
transmembrane O
protein O
and O
, O
like O
SR B
alpha I
and O
SRP54 B
, O
is O
a O
member O
of O
the O
GTPase B
superfamily I
. O

Molecular O
cloning O
and O
sequencing O
of O
a O
cDNA O
encoding O
SR B
beta I
revealed O
that O
SR B
beta I
is O
a O
transmembrane O
protein O
and O
, O
like O
SR B
alpha I
and O
SRP54 B
, O
is O
a O
member O
of O
the O
GTPase B
superfamily I
. O

The O
plant O
hormone O
auxin O
transcriptionally O
activates O
early B
genes I
. O

Oseltamivir O
( O
GS4104 O
) O
, O
which O
can O
be O
administered O
orally O
, O
is O
the O
prodrug O
of O
GS4071 O
, O
a O
potent O
and O
selective O
inhibitor O
of O
influenzavirus B
neuraminidases I
. O

Removal O
of O
the O
GST B
domain I
from O
GST B
- O
Tax B
by O
thrombin B
restores O
Tax B
' O
s O
ability O
to O
assemble O
a O
ternary O
Tax B
- O
CREB B
- O
21 O
- O
bp O
- O
repeat O
complex O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
400 O
WORDS O
) O

In O
the O
normal O
, O
basal O
( O
unstimulated O
) O
condition O
there O
were O
no O
significant O
correlations O
( O
p O
greater O
than O
0 O
. O
05 O
) O
between O
the O
systolic O
blood O
pressure O
and O
dopamine O
( O
r O
= O
0 O
. O
09 O
) O
, O
norepinephrine O
( O
r O
= O
0 O
. O
26 O
) O
, O
or O
epinephrine O
( O
r O
= O
0 O
. O
27 O
) O
, O
nor O
were O
there O
significant O
correlations O
between O
melatonin O
and O
dopamine O
( O
r O
= O
- O
0 O
. O
01 O
) O
, O
norepinephrine O
( O
r O
= O
- O
0 O
. O
26 O
) O
, O
or O
growth B
hormone I
( O
r O
= O
0 O
. O
17 O
) O
. O

The O
major O
promoter O
responds O
strongly O
to O
virus O
- O
encoded O
trans O
activators O
EIA B
and O
EIV B
and O
contains O
four O
elements O
: O
a O
TAGA O
motif O
analogous O
to O
the O
TATA O
box O
, O
two O
EIIF B
sites I
present O
in O
an O
inverted O
orientation O
, O
and O
an O
ATF B
/ O
CREB B
site O
. O

To O
confirm O
the O
GapIII B
protein I
activity O
, O
constructs O
containing O
different O
GapIII B
- O
GRD B
domains O
were O
transformed O
into O
iral B
mutant O
yeast O
to O
determine O
their O
relative O
ability O
to O
replace O
IRA1 B
functionally O
. O

These O
cell O
lines O
, O
selected O
for O
the O
ability O
to O
support O
the O
replication O
of O
a O
temperature O
- O
sensitive O
VP5 B
mutant I
, O
were O
used O
to O
isolate O
VP5 B
and O
VP23 B
null O
mutants O
. O

Because O
the O
Pit B
- I
1 I
sites I
in O
the O
hGH B
- I
N I
gene I
promoter I
are O
insufficient O
for O
such O
gene O
activation O
in O
vivo O
, O
these O
data O
suggested O
a O
unique O
chromatin O
- O
mediated O
developmental O
role O
for O
Pit B
- I
1 I
in O
the O
hGH B
LCR I
. O

A O
triple O
Ser O
- O
- O
> O
Ala O
mutant O
form O
of O
yeast O
eIF B
- I
2 I
alpha I
was O
found O
to O
be O
no O
longer O
phosphorylated O
by O
either O
of O
the O
yeast O
( O
or O
mammalian O
) O
casein B
kinase I
activities O
in O
vitro O
. O

The O
E1 B
nuclear I
transport I
motif I
is O
highly O
conserved O
in O
the O
animal O
and O
human O
papillomaviruses O
and O
is O
encoded O
in O
a O
similar O
region O
in O
the O
related O
E1 B
genes I
. O

The O
studied O
protein O
fragments O
consist O
of O
residues O
Arg183 O
- O
His267 O
of O
the O
human B
ER I
and O
residues O
Lys438 O
- O
Gln520 O
of O
the O
rat O
GR B
. O

In O
co O
- O
transfection O
studies O
, O
an O
AP B
- I
2 I
but O
not O
an O
Egr B
- I
1 I
expression O
vector O
activated O
VPF B
/ O
VEGF B
transcription O
, O
thus O
indicating O
that O
AP B
- I
2 I
protein I
is O
functionally O
important O
in O
TGF B
alpha I
- O
induced O
VPF B
/ O
VEGF B
gene O
expression O
. O

Reverse B
transcriptase I
and O
protease O
activities O
of O
avian O
leukosis O
virus O
Gag B
- O
Pol B
fusion O
proteins O
expressed O
in O
insect O
cells O
. O

Thus O
, O
multiple O
myogenic O
factors O
that O
vary O
qualitatively O
and O
quantitatively O
may O
be O
responsible O
for O
the O
different O
and O
complex O
modulatory O
programs O
of O
actin B
gene I
expression O
observed O
during O
in O
vivo O
muscle O
differentiation O
. O

The O
codon O
usage O
is O
particularly O
marked O
for O
the O
gag B
, O
pol B
, O
and O
env B
genes I
. O

( O
1989 O
) O
, O
which O
is O
identical O
to O
the O
SSC1 B
gene I
( O
Smith O
et O
al O
. O
, O
1988 O
) O
. O

Here O
, O
we O
present O
evidence O
that O
exposure O
of O
DT40 O
lymphoma O
B O
cells O
to O
low O
energy O
electromagnetic O
field O
( O
EMF O
) O
results O
in O
a O
tyrosine B
kinase I
- O
dependent O
activation O
of O
phospholipase B
Cgamma2 I
( O
PLC B
- I
gamma2 I
) O
leading O
to O
increased O
inositol O
phospholipid O
turnover O
. O

Here O
, O
we O
present O
evidence O
that O
exposure O
of O
DT40 O
lymphoma O
B O
cells O
to O
low O
energy O
electromagnetic O
field O
( O
EMF O
) O
results O
in O
a O
tyrosine B
kinase I
- O
dependent O
activation O
of O
phospholipase B
Cgamma2 I
( O
PLC B
- I
gamma2 I
) O
leading O
to O
increased O
inositol O
phospholipid O
turnover O
. O

Two O
splice O
variants O
of O
ALF1 B
cDNA I
have O
been O
found O
, O
differing O
by O
a O
72 O
- O
bp O
insertion O
, O
coding O
for O
putative O
proteins O
of O
682 O
and O
706 O
amino O
acids O
. O

The O
class B
II I
Escherichia I
coli I
alanine I
tRNA I
synthetase I
aminoacylates I
RNA I
miniduplexes I
, O
which O
reconstruct O
the O
acceptor O
end O
of O
alanine B
tRNA I
with O
the O
critical O
G3 O
: O
U70 O
base O
pair O
. O

The O
results O
indicate O
that O
hrpRS B
and O
hrpL B
are O
part O
of O
a O
regulatory O
cascade O
in O
which O
HrpR B
and O
HrpS B
activate O
expression O
of O
hrpL B
and O
HrpL B
, O
a O
putative O
sigma B
factor I
, O
induces O
expression O
of O
HrpL B
- I
responsive I
genes I
. O

These O
findings O
suggest O
one O
potential O
mechanism O
for O
direct O
recruitment O
of O
distal O
regulatory O
regions O
of O
the O
globin B
loci I
to O
the O
individual O
promoters O
. O

Moreover O
, O
the O
hypoxia O
- O
induced O
expression O
of O
the O
endogenous O
Epo B
gene I
was O
significantly O
inhibited O
in O
Hep3B O
cells O
stably O
transfected O
with O
HNF B
- I
4 I
delta I
C I
. O

ID O
- O
PaGIA O
diphtheria B
toxin I
polymer O
particle O
diagnostic O
agent O
manufactured O
by O
DiaMed O
AG O
, O
Switzerland O
, O
was O
tried O
at O
bacteriological O
laboratory O
of O
Institute O
of O
Childhood O
Infections O
in O
St O
. O

Effects O
of O
a O
perfluorochemical O
blood O
substitute O
on O
diazepam O
binding O
by O
human B
albumin I
. O

As O
expected O
, O
the O
insulin B
effect O
to O
increase O
ras B
GTP I
formation O
and O
MAP B
kinase I
activity O
was O
negligible O
in O
A O
/ O
K1018 O
cells O
but O
normal O
, O
or O
supernormal O
, O
in O
Y O
/ O
F2 O
cells O
. O

As O
expected O
, O
the O
insulin B
effect O
to O
increase O
ras B
GTP I
formation O
and O
MAP B
kinase I
activity O
was O
negligible O
in O
A O
/ O
K1018 O
cells O
but O
normal O
, O
or O
supernormal O
, O
in O
Y O
/ O
F2 O
cells O
. O

The O
protein O
product O
of O
orfD B
, O
which O
is O
probably O
a O
new O
tra B
gene I
( O
named O
traX B
) O
, O
contains O
65 O
% O
hydrophobic O
amino O
acids O
, O
especially O
rich O
in O
alanine O
and O
leucine O
. O

Six O
distinct O
Ets B
mRNAs I
were O
identified O
: O
Ets2 B
, O
Fli1 B
, O
GABPalpha B
, O
SAP1 B
, O
Elk1 B
, O
and O
PE1 B
. O

These O
two O
repeat O
motifs O
are O
organized O
in O
an O
extremely O
well O
- O
ordered O
pattern O
in O
each O
domain O
, O
which O
suggests O
that O
SbHRGP3 B
belongs O
to O
a O
new O
group O
of O
proteins O
having O
the O
repeat O
motifs O
of O
two O
distinct O
groups O
of O
dicot B
extensins I
. O

Both O
NUP98 B
- O
HOXA9 B
chimeras O
transformed O
NIH O
3T3 O
fibroblasts O
, O
and O
this O
transformation O
required O
the O
HOXA9 B
domains I
for O
DNA O
binding O
and O
PBX B
interaction O
. O

RESULTS O
: O
Patients O
in O
Group O
A O
had O
a O
higher O
incidence O
of O
posterolateral O
wall O
motion O
abnormalities O
( O
p O
< O
0 O
. O
001 O
) O
on O
radionuclide O
ventriculography O
, O
a O
larger O
infarct O
area O
( O
as O
evidenced O
by O
higher O
peak O
creatine B
kinase I
levels O
) O
( O
p O
< O
0 O
. O
02 O
) O
and O
a O
lower O
left O
ventricular O
ejection O
fraction O
( O
LVEF O
) O
at O
hospital O
discharge O
( O
p O
< O
0 O
. O
008 O
) O
than O
those O
in O
Group O
B O
. O

The O
MSL B
complex I
is O
specifically O
localized O
on O
the O
male O
X O
chromosome O
to O
increase O
its O
expression O
approximately O
2 O
- O
fold O
. O

However O
, O
cotransfection O
studies O
indicate O
that O
RVR B
does O
not O
activate O
transcription O
when O
this O
hormone O
response O
element O
is O
linked O
to O
a O
reporter O
gene O
but O
rather O
acts O
as O
a O
potent O
competitive O
repressor O
of O
ROR B
alpha I
function O
. O

The O
selenium O
level O
and O
glutathione B
peroxidase I
activity O
in O
the O
blood O
, O
liver O
, O
and O
stomach O
mucosa O
were O
significantly O
higher O
in O
the O
high O
- O
selenium O
diet O
group O
than O
in O
the O
low O
- O
selenium O
diet O
group O
. O

Previous O
genetic O
studies O
led O
to O
the O
conclusion O
that O
nitrate O
and O
nitrite O
induction O
of O
nasF B
operon I
expression O
is O
determined O
by O
a O
transcriptional O
antitermination O
mechanism O
. O

We O
have O
characterized O
a O
panel O
of O
6 O
monoclonal O
antibodies O
raised O
against O
human B
platelet I
talin I
by O
Western O
blotting O
, O
immune O
precipitation O
, O
and O
immunofluorescence O
, O
and O
shown O
that O
antibodies B
TA205 I
and O
TD77 B
disrupt O
actin B
stress O
fibers O
and O
focal O
adhesions O
, O
and O
inhibit O
cell O
motility O
when O
microinjected O
into O
human O
fibroblasts O
. O

This O
paper O
summarises O
the O
experimental O
evidence O
upon O
which O
the O
clinical O
trials O
of O
aldose B
reductase I
inhibitors O
in O
diabetic O
patients O
have O
been O
initiated O
and O
the O
results O
of O
published O
drug O
trials O
in O
these O
patients O
. O

In O
these O
constructs O
, O
GUS B
expression O
was O
driven O
by O
promoter O
regions O
derived O
from O
the O
Arabidopsis B
alcohol I
dehydrogenase I
( O
Adh1 B
) O
, O
maize B
ubiquitin I
( O
Ubi1 B
) O
, O
rice B
actin I
( O
Act1 B
) O
and O
CaMV B
35S I
genes I
. O

In O
these O
constructs O
, O
GUS B
expression O
was O
driven O
by O
promoter O
regions O
derived O
from O
the O
Arabidopsis B
alcohol I
dehydrogenase I
( O
Adh1 B
) O
, O
maize B
ubiquitin I
( O
Ubi1 B
) O
, O
rice B
actin I
( O
Act1 B
) O
and O
CaMV B
35S I
genes I
. O

In O
this O
regard O
, O
it O
differs O
from O
a O
recently O
reported O
BFA O
- O
sensitive O
ARF B
- O
GEP B
that O
contains O
a O
Sec7 B
domain I
. O

The O
Spo0F B
residues I
making O
up O
the O
hydrophobic O
patch O
are O
very O
similar O
in O
all O
response O
regulators O
suggesting O
that O
the O
binding O
is O
initiated O
through O
the O
same O
residues O
in O
all O
interacting O
response O
regulator O
- O
kinase O
pairs O
. O

In O
the O
United O
States O
high O
- O
MW O
HES O
480 O
which O
is O
difficult O
to O
degrade O
is O
most O
frequently O
used O
and O
results O
in O
a O
larger O
in O
vivo O
MW O
and O
subsequent O
decrease O
in O
factor B
VIII I
/ O
von B
Willebrand I
factor I
levels O
. O

All O
ribosomal B
protein I
( O
rp B
) O
gene O
promoters O
from O
Saccharomyces O
cerevisiae O
studied O
so O
far O
contain O
either O
( O
usually O
two O
) O
binding O
sites O
for O
the O
global O
gene O
regulator O
Rap1p B
or O
one O
binding O
site O
for O
another O
global O
factor O
, O
Abf1p B
. O

All O
three O
NR B
isoforms I
are O
expressed O
in O
cv O
. O

We O
have O
cloned O
cDNA O
and O
genomic O
DNA O
for O
a O
mouse O
gene O
encoding O
a O
protein O
with O
significant O
sequence O
similarity O
to O
conserved O
domains O
found O
in O
proteins O
of O
the O
Spo11p B
family I
. O

The O
transcription O
initiation O
site O
was O
determined O
by O
S1 B
nuclease I
mapping O
. O

The O
number O
of O
lactotropes O
, O
somatotropes O
, O
thyrotropes O
, O
and O
gonadotropes O
was O
not O
altered O
compared O
with O
controls O
, O
indicating O
that O
in O
the O
adult O
pituitary O
, O
POMC B
products I
are O
not O
required O
to O
maintain O
the O
distribution O
of O
cell O
types O
. O

Structure O
and O
regulation O
of O
the O
gene O
encoding O
the O
neuron O
- O
specific O
protein B
kinase I
C I
substrate O
neurogranin B
( O
RC3 B
protein I
) O
. O

Mutations O
of O
the O
RET B
gene I
, O
encoding O
a O
receptor B
tyrosine I
kinase I
, O
have O
been O
associated O
with O
the O
inherited O
cancer O
syndromes O
MEN O
2A O
and O
MEN O
2B O
. O

Members O
of O
the O
meis1 B
and O
pbx B
homeodomain I
protein I
families I
cooperatively O
bind O
a O
cAMP O
- O
responsive O
sequence O
( O
CRS1 O
) O
from O
bovine B
CYP17 I
. O

The O
novel O
Notch B
homologue I
mouse B
Notch I
3 I
lacks O
specific O
epidermal B
growth I
factor I
- I
repeats I
and O
is O
expressed O
in O
proliferating O
neuroepithelium O
. O

The O
role O
of O
HIV B
tat I
, O
which O
is O
the O
main O
enhancing O
factor O
for O
viral B
LTR I
, O
in O
the O
regulation O
of O
IL B
- I
2 I
gene I
transcription O
has O
been O
studied O
following O
transient O
expression O
of O
the O
tat B
gene I
in O
phorbol O
ester O
and O
calcium O
ionophore O
- O
activated O
Jurkat O
cells O
transfected O
with O
IL B
- I
2 I
promoter O
- O
chloramphenicol B
acetyltransferase I
reporter O
constructs O
. O

The O
role O
of O
HIV B
tat I
, O
which O
is O
the O
main O
enhancing O
factor O
for O
viral B
LTR I
, O
in O
the O
regulation O
of O
IL B
- I
2 I
gene I
transcription O
has O
been O
studied O
following O
transient O
expression O
of O
the O
tat B
gene I
in O
phorbol O
ester O
and O
calcium O
ionophore O
- O
activated O
Jurkat O
cells O
transfected O
with O
IL B
- I
2 I
promoter O
- O
chloramphenicol B
acetyltransferase I
reporter O
constructs O
. O

The O
role O
of O
HIV B
tat I
, O
which O
is O
the O
main O
enhancing O
factor O
for O
viral B
LTR I
, O
in O
the O
regulation O
of O
IL B
- I
2 I
gene I
transcription O
has O
been O
studied O
following O
transient O
expression O
of O
the O
tat B
gene I
in O
phorbol O
ester O
and O
calcium O
ionophore O
- O
activated O
Jurkat O
cells O
transfected O
with O
IL B
- I
2 I
promoter O
- O
chloramphenicol B
acetyltransferase I
reporter O
constructs O
. O

The O
role O
of O
HIV B
tat I
, O
which O
is O
the O
main O
enhancing O
factor O
for O
viral B
LTR I
, O
in O
the O
regulation O
of O
IL B
- I
2 I
gene I
transcription O
has O
been O
studied O
following O
transient O
expression O
of O
the O
tat B
gene I
in O
phorbol O
ester O
and O
calcium O
ionophore O
- O
activated O
Jurkat O
cells O
transfected O
with O
IL B
- I
2 I
promoter O
- O
chloramphenicol B
acetyltransferase I
reporter O
constructs O
. O

Analysis O
of O
its O
genomic O
region O
revealed O
that O
the O
13 O
- O
kb O
Cdc6 B
gene I
is O
divided O
into O
12 O
exons O
by O
11 O
introns O
. O

We O
have O
performed O
toeprinting O
analyses O
on O
repA B
mRNA I
of O
plasmid O
R1 O
, O
both O
free O
and O
in O
duplex O
with O
the O
antisense O
RNA O
, O
CopA B
. O

An O
FP B
mutant I
, O
AcFP875 B
- I
2 I
, O
had O
a O
1 O
. O
6 O
- O
kbp O
insertion O
of O
S O
. O
frugiperda O
DNA O
near O
the O
5 O
' O
end O
of O
these O
transcripts O
which O
by O
S1 B
analysis O
were O
shown O
to O
initiate O
within O
the O
host O
cell O
sequence O
. O

These O
data O
suggest O
that O
other O
Ras B
effectors I
can O
collaborate O
with O
PI B
3 I
- I
kinase I
and O
with O
each O
other O
to O
activate O
Pak B
. O

Mutations O
at O
the O
extreme O
C O
- O
terminus O
of O
EIAV B
Tat I
impaired O
both O
RNA O
binding O
and O
activation O
domain O
functions O
, O
suggesting O
effects O
on O
secondary O
or O
tertiary O
structure O
. O

We O
have O
shown O
previously O
that O
in O
contrast O
to O
other O
extracellular O
matrix O
molecules O
pepsin B
- O
solubilized O
collagen B
VI I
( O
CVI B
) O
can O
stimulate O
DNA O
synthesis O
of O
various O
mesenchymal O
cell O
types O
, O
apparently O
independent O
of O
integrin B
- O
mediated O
signal O
transduction O
. O

Although O
IL B
- I
2 I
and O
IFN B
- I
alpha I
activated O
STAT1 B
alpha I
and O
STAT5 B
, O
IL B
- I
2 I
predominantly O
activated O
STAT5 B
, O
while O
IFN B
- I
alpha I
predominantly O
activated O
STAT1 B
alpha I
. O

Although O
IL B
- I
2 I
and O
IFN B
- I
alpha I
activated O
STAT1 B
alpha I
and O
STAT5 B
, O
IL B
- I
2 I
predominantly O
activated O
STAT5 B
, O
while O
IFN B
- I
alpha I
predominantly O
activated O
STAT1 B
alpha I
. O

To O
understand O
the O
function O
of O
receptor B
- I
linked I
tyrosine I
phosphatases I
in O
neural O
development O
, O
we O
sought O
to O
identify O
LAR B
isoforms I
preferentially O
expressed O
in O
the O
nervous O
system O
and O
cellular O
processes O
regulating O
LAR B
alternative O
splicing O
. O

p50 B
homodimers I
replace O
Sp1 B
from O
the O
P B
- I
selectin I
promoter I
by O
binding O
site O
competition O
and O
thereby O
either O
inhibit O
basal O
Sp1 B
- O
driven O
expression O
or O
, O
in O
concert O
with O
Bcl B
- I
3 I
, O
stimulate O
expression O
. O

Upstream O
activation O
sites O
of O
the O
CYC1 B
gene I
of O
Saccharomyces O
cerevisiae O
are O
active O
when O
inverted O
but O
not O
when O
placed O
downstream O
of O
the O
" O
TATA O
box O
" O
. O

The O
gene O
product O
of O
cotS B
was O
confirmed O
to O
be O
identical O
to O
Cot40 B
- I
2 I
by O
SDS O
- O
PAGE O
and O
immunoblotting O
from O
Escherichia O
coli O
transformed O
with O
a O
plasmid O
containing O
the O
cotS B
region I
. O

Apart O
from O
iron O
regulation O
, O
sodA B
expression O
was O
affected O
by O
changes O
in O
DNA O
topology O
induced O
by O
coumermycin O
A O
but O
not O
by O
the O
global O
virulence O
regulatory O
Bvg B
system I
. O

The O
significance O
of O
the O
phenolphthalein B
sulphatase I
test O
for O
the O
differentiation O
and O
identification O
of O
Nocardia O
species O
. O

The O
genetic O
basis O
for O
the O
expression O
of O
a O
latent O
VH B
allotype I
in O
the O
rabbit O
was O
investigated O
. O

A O
5 O
. O
0 O
- O
kb O
transcript O
detected O
by O
the O
differential O
display O
amplicon O
3G1 O
was O
found O
to O
correlate O
strongly O
with O
RAG1 B
mRNA I
expression O
in O
various O
human O
cell O
lines O
. O

Here O
we O
describe O
the O
identification O
and O
characterization O
of O
several O
Sp100 B
splice I
variant I
proteins I
and O
support O
their O
existence O
by O
elucidation O
of O
the O
3 O
' O
- O
end O
of O
the O
Sp100 B
gene I
. O

A O
motif O
( O
TGATGTCA O
) O
which O
matches O
a O
CREB B
site I
and O
is O
similar O
to O
an O
AP B
- I
1 I
site I
is O
embedded O
within O
ER2 B
. O

In O
the O
case O
of O
congenital O
protein B
C I
deficiency O
, O
vitamin O
K O
antagonists O
must O
be O
started O
cautiously O
due O
to O
the O
risk O
of O
skin O
necrosis O
. O

Using O
anchored O
PCR O
, O
a O
VL B
element I
rearranged O
to O
CL2 B
was O
isolated O
. O

In O
the O
point O
mutant O
we O
observed O
normal O
repair O
of O
endonuclease B
III I
site I
( O
i O
. O
e O
. O
as O
wild O
type O
) O
, O
but O
no O
removal O
of O
CPDs O
at O
the O
MAT B
alpha I
and O
HML B
alpha I
loci I
. O

Marked O
thrombocytopenia O
, O
depletion O
of O
serum B
fibrinogen I
and O
prolonged O
prothrombin B
and O
activated O
partial O
thromboplastin B
time O
, O
were O
recorded O
at O
5 O
to O
10 O
and O
30 O
to O
40 O
minutes O
after O
intravenous O
envenomation O
. O

Serum O
induction O
of O
a O
MEF2 B
reporter I
gene I
was O
not O
observed O
in O
a O
line O
of O
NIH O
3T3 O
cells O
which O
contain O
low O
MEF2 B
site I
binding O
activity O
. O

Competitive O
mobility O
shift O
assays O
using O
either O
alphaT3 O
- O
1 O
nuclear O
extract O
or O
recombinant B
SF I
- I
1 I
protein I
clearly O
indicated O
that O
SF B
- I
1 I
is O
able O
to O
interact O
specifically O
with O
this O
GSE B
element I
positioned O
at O
- O
134 O
. O

Also O
, O
samples O
of O
serum O
were O
absorbed O
with O
the O
various O
solid O
- O
phase O
allergens O
and O
the O
reactivity O
of O
the O
remaining O
IgE B
antibodies I
was O
determined O
. O

Southern O
blot O
analysis O
using O
probes O
from O
the O
3 O
' O
portions O
of O
the O
genomic O
and O
B B
. I
napus I
MA I
and O
MB B
cDNA I
clones O
showed O
that O
MA B
type I
myrosinases B
are O
encoded O
by O
approximately O
4 O
genes O
, O
while O
MB B
type I
myrosinases B
are O
encoded O
by O
more O
than O
10 O
genes O
in O
B O
. O
napus O
. O

Southern O
blot O
analysis O
using O
probes O
from O
the O
3 O
' O
portions O
of O
the O
genomic O
and O
B B
. I
napus I
MA I
and O
MB B
cDNA I
clones O
showed O
that O
MA B
type I
myrosinases B
are O
encoded O
by O
approximately O
4 O
genes O
, O
while O
MB B
type I
myrosinases B
are O
encoded O
by O
more O
than O
10 O
genes O
in O
B O
. O
napus O
. O

Southern O
blot O
analysis O
using O
probes O
from O
the O
3 O
' O
portions O
of O
the O
genomic O
and O
B B
. I
napus I
MA I
and O
MB B
cDNA I
clones O
showed O
that O
MA B
type I
myrosinases B
are O
encoded O
by O
approximately O
4 O
genes O
, O
while O
MB B
type I
myrosinases B
are O
encoded O
by O
more O
than O
10 O
genes O
in O
B O
. O
napus O
. O

The O
XS2 B
gene I
down O
- O
regulates O
but O
does O
not O
abolish O
expression O
of O
LU B
genes I
and O
does O
not O
affect O
expression O
of O
CD44 B
. O

The O
XS2 B
gene I
down O
- O
regulates O
but O
does O
not O
abolish O
expression O
of O
LU B
genes I
and O
does O
not O
affect O
expression O
of O
CD44 B
. O

Northern O
analysis O
of O
RNA O
samples O
isolated O
from O
ammonium O
- O
grown O
cultures O
of O
the O
ntcA B
mutant I
showed O
reduced O
amounts O
of O
glnA B
message I
and O
the O
absence O
of O
a O
1 O
. O
7 O
- O
kb O
transcript O
. O

Northern O
analysis O
of O
RNA O
samples O
isolated O
from O
ammonium O
- O
grown O
cultures O
of O
the O
ntcA B
mutant I
showed O
reduced O
amounts O
of O
glnA B
message I
and O
the O
absence O
of O
a O
1 O
. O
7 O
- O
kb O
transcript O
. O

Surprisingly O
, O
the O
RXR B
- O
specific O
ligand O
9 O
- O
cis O
- O
retinoic O
acid O
induced O
binding O
of O
SRC B
- I
1 I
to O
the O
RXR B
component I
of O
the O
TRE O
- O
bound O
heterodimer O
. O

4 O
. O
26 O
+ O
/ O
- O
1 O
. O
54 O
mmol O
/ O
l O
, O
P O
< O
0 O
. O
01 O
) O
, O
and O
systolic O
BP O
responses O
to O
intravenous O
norepinephrine O
and O
angiotensin B
II I
were O
significantly O
higher O
on O
glibenclamide O
than O
on O
metformin O
( O
P O
< O
0 O
. O
02 O
and O
P O
< O
0 O
. O
05 O
, O
respectively O
) O
. O

Precipitation O
using O
GST B
fusion I
proteins I
containing O
Fyn B
SH2 B
, O
SH3 B
, O
and O
SH2 B
/ O
SH3 B
domains O
revealed O
that O
PI B
3 I
- I
kinase I
bound O
principally O
to O
the O
SH3 B
domain I
of O
Fyn B
. O

Plasma O
and O
erthrocyte O
lipid O
profile O
and O
lipoprotein B
lipase I
activity O
in O
postheparin O
plasma O
on O
vasectomized O
rabbits O
were O
studied O
and O
also O
the O
incidence O
of O
atherosclerosis O
in O
different O
arterial O
beds O
. O

Electromobility O
shift O
and O
cotransfection O
assays O
demonstrated O
that O
HNF1alpha B
, O
but O
not O
HNF4 B
, O
bound O
to O
its O
cognate O
site O
and O
transactivated O
G6Pase B
gene I
expression O
. O

Stable O
transfection O
of O
the O
BL O
cell O
line O
Raji O
with O
constructs O
containing O
core O
promoter O
mutations O
confirmed O
that O
the O
proximal O
Sp1 B
site I
and O
the O
TATA O
box O
are O
essential O
for O
the O
activation O
of O
promoter O
P1 O
by O
the O
Ig B
kappa I
enhancers I
. O

Levels O
of O
the O
MEK B
inhibitor O
PD98059 O
that O
block O
EGF B
- O
induced O
mitogenesis O
and O
MAP B
kinase I
phosphorylation O
also O
abrogate O
EGF B
- O
induced O
focal O
adhesion O
disassembly O
and O
cell O
motility O
. O

The O
predicted O
L B
mRNA I
was O
6398 O
nucleotides O
long O
and O
contained O
a O
single O
open O
reading O
frame O
corresponding O
to O
an O
L B
protein I
encompassing I
2109 I
amino I
acids I
with O
a O
MW O
of O
241 O
, O
546 O
. O

Entry O
of O
yeast O
cells O
into O
the O
mitotic O
cell O
cycle O
( O
Start O
) O
involves O
a O
form O
of O
the O
CDC28 B
kinase I
that O
associates O
with O
G1 O
- O
specific O
cyclins B
encoded O
by O
CLN1 B
and O
CLN2 B
( O
ref O
. O

UDP B
- I
Gal I
: I
Gal I
beta I
1 I
- I
- I
- I
- I
4GlcNAc I
alpha I
1 I
- I
- I
- I
- I
3 I
- I
galactosyltransferase I
is O
a O
terminal B
glycosyltransferase I
that O
is O
widely O
expressed O
in O
a O
variety O
of O
mammalian O
species O
, O
with O
the O
notable O
exception O
of O
man O
, O
apes O
, O
and O
Old O
World O
monkeys O
. O

USF B
synthesized O
in O
an O
in O
vitro O
transcription O
and O
translation O
system O
also O
binds O
to O
the O
ADH B
promoter I
as O
well O
as O
to O
the O
MLP O
. O

Wild B
- I
type I
AT1A I
receptors I
, O
expressed O
in O
Chinese O
hamster O
ovary O
cells O
, O
rapidly O
internalized O
after O
Ang B
II I
stimulation O
[ O
t1 O
/ O
2 O
2 O
. O
3 O
min O
; O
maximal O
level O
of O
internalization O
( O
Ymax O
) O
78 O
. O
2 O
% O
] O
, O
as O
did O
mutant O
receptors O
carrying O
single O
acidic O
substitutions O
( O
T332E O
, O
t1 O
/ O
2 O
2 O
. O
7 O
min O
, O
Ymax O
76 O
. O
3 O
% O
; O
S335D O
, O
t1 O
/ O
2 O
2 O
. O
4 O
min O
, O
Ymax O
76 O
. O
7 O
% O
; O
T336E O
, O
t1 O
/ O
2 O
2 O
. O
5 O
min O
, O
Ymax O
78 O
. O
2 O
% O
; O

In O
the O
brain O
, O
muscarinic B
receptors I
mediate O
motor O
and O
memory O
function O
by O
interaction O
with O
their O
ligand O
acetylcholine O
. O

Quantitation O
of O
exocrine B
IgA I
in O
human O
serum O
in O
health O
and O
disease O
. O

Furthermore O
, O
we O
have O
identified O
a O
43 O
- O
bp O
region O
of O
the O
24p3 B
promoter I
required O
for O
the O
Dex O
responsiveness O
. O

Polysome O
and O
40S B
ribosome I
fractions O
were O
severely O
decreased O
in O
the O
krr1 B
mutant I
and O
Kri1p B
- O
depleted O
cells O
. O

Polysome O
and O
40S B
ribosome I
fractions O
were O
severely O
decreased O
in O
the O
krr1 B
mutant I
and O
Kri1p B
- O
depleted O
cells O
. O

Our O
results O
indicate O
that O
the O
KRAB B
domain I
present O
in O
the O
non O
- O
finger O
region O
of O
many O
ZFP B
genes I
quenches O
transcription O
possibly O
due O
to O
specific O
protein O
- O
protein O
interactions O
between O
the O
KRAB B
- I
A I
domain I
and O
components O
of O
the O
proximal O
transcriptional O
apparatus O
. O

Our O
results O
indicate O
that O
the O
KRAB B
domain I
present O
in O
the O
non O
- O
finger O
region O
of O
many O
ZFP B
genes I
quenches O
transcription O
possibly O
due O
to O
specific O
protein O
- O
protein O
interactions O
between O
the O
KRAB B
- I
A I
domain I
and O
components O
of O
the O
proximal O
transcriptional O
apparatus O
. O

Systematic O
functional O
analysis O
of O
V1a B
/ I
V2 I
hybrid I
receptors I
showed O
that O
the O
second O
intracellular O
loop O
of O
the O
V1a B
receptor I
is O
required O
and O
sufficient O
for O
efficient O
coupling O
to O
Gq B
/ I
11 I
, O
whereas O
the O
third O
intracellular O
loop O
of O
the O
V2 B
receptor I
is O
required O
and O
sufficient O
for O
coupling O
to O
Gs B
. O

Systematic O
functional O
analysis O
of O
V1a B
/ I
V2 I
hybrid I
receptors I
showed O
that O
the O
second O
intracellular O
loop O
of O
the O
V1a B
receptor I
is O
required O
and O
sufficient O
for O
efficient O
coupling O
to O
Gq B
/ I
11 I
, O
whereas O
the O
third O
intracellular O
loop O
of O
the O
V2 B
receptor I
is O
required O
and O
sufficient O
for O
coupling O
to O
Gs B
. O

To O
determine O
whether O
P35 B
could O
activate O
the O
39k O
promoter O
in O
the O
absence O
of O
IE1 B
, O
the O
p35 B
open O
reading O
frame O
was O
cloned O
under O
the O
control O
of O
the O
ie1 B
promoter I
. O

The O
hypertension O
with O
elevated O
PRA O
, O
however O
, O
was O
resistant O
to O
the O
angiotensin B
II I
( O
AII B
) O
analog O
[ O
Sar1 O
, O
Ile8 O
] O
ALL O
. O

These O
data O
show O
that O
PTH B
and O
cAMP O
can O
repress O
collagen B
promoter I
activity O
in O
calvariae O
from O
transgenic O
mice O
, O
suggesting O
that O
the O
alpha B
1 I
( I
I I
) I
collagen I
promoter I
may O
contain O
cis O
elements O
down O
- O
stream O
of O
- O
2 O
. O
3 O
kilobases O
that O
mediate O
PTH B
and O
cAMP O
repression O
of O
collagen B
gene I
expression O
in O
bone O
. O

These O
data O
show O
that O
PTH B
and O
cAMP O
can O
repress O
collagen B
promoter I
activity O
in O
calvariae O
from O
transgenic O
mice O
, O
suggesting O
that O
the O
alpha B
1 I
( I
I I
) I
collagen I
promoter I
may O
contain O
cis O
elements O
down O
- O
stream O
of O
- O
2 O
. O
3 O
kilobases O
that O
mediate O
PTH B
and O
cAMP O
repression O
of O
collagen B
gene I
expression O
in O
bone O
. O

Reconstitution O
of O
complexes O
containing O
p62 B
and O
the O
src B
family I
kinase I
p59fyn B
in O
HeLa O
cells O
demonstrated O
that O
complex O
formation O
resulted O
in O
tyrosine O
phosphorylation O
of O
p62 B
and O
was O
mediated O
by O
both O
the O
SH3 B
and O
SH2 B
domains I
of O
p59fyn B
. O

The O
second O
patient O
had O
received O
pituitary B
- I
derived I
growth I
hormone I
for O
treatment O
of O
growth B
hormone I
deficiency O
, O
secondary O
to O
a O
third O
ventricle O
teratoma O
, O
exised O
13 O
yr O
earlier O
. O

We O
have O
identified O
and O
characterized O
the O
structure O
of O
the O
Spec1 B
gene I
in O
the O
sea O
urchin O
Strongylocentrotus O
purpuratus O
. O

Analysis O
of O
the O
gag B
and O
rev B
proteins I
in O
the O
transfected O
cells O
demonstrated O
that O
these O
proteins O
were O
not O
detectable O
in O
cells O
transfected O
with O
the O
tat B
mutants I
but O
could O
be O
readily O
detected O
when O
the O
mutations O
were O
complemented O
in O
trans O
with O
a O
tat B
expression O
vector O
. O

Analysis O
of O
the O
gag B
and O
rev B
proteins I
in O
the O
transfected O
cells O
demonstrated O
that O
these O
proteins O
were O
not O
detectable O
in O
cells O
transfected O
with O
the O
tat B
mutants I
but O
could O
be O
readily O
detected O
when O
the O
mutations O
were O
complemented O
in O
trans O
with O
a O
tat B
expression O
vector O
. O

Small B
GTPases I
of O
the O
Ypt B
/ O
Rab B
family O
are O
involved O
in O
the O
regulation O
of O
vesicular O
transport O
. O

Certain O
spt10 B
spontaneous O
alleles O
are O
good O
suppressors O
but O
have O
a O
normal O
growth O
rate O
, O
suggesting O
that O
the O
SPT10 B
protein I
may O
have O
two O
distinct O
functions O
. O

This O
spindle O
defect O
of O
pds1 B
mutants I
results O
from O
a O
temperature O
- O
sensitive O
step O
that O
occurs O
around O
the O
G1 O
/ O
S O
boundary O
about O
the O
time O
of O
spindle O
assembly O
. O

Stimulation O
of O
[ O
3H O
] O
PA O
production O
upon O
CD3 B
cross O
- O
linking O
was O
77 O
% O
lower O
in O
permeabilized O
CD45 B
- I
cells O
than O
in O
CD45 B
+ I
cells O
, O
consistent O
with O
the O
reduced O
activity O
of O
p59fyn B
in O
CD45 B
- I
cells O
. O

Stimulation O
of O
[ O
3H O
] O
PA O
production O
upon O
CD3 B
cross O
- O
linking O
was O
77 O
% O
lower O
in O
permeabilized O
CD45 B
- I
cells O
than O
in O
CD45 B
+ I
cells O
, O
consistent O
with O
the O
reduced O
activity O
of O
p59fyn B
in O
CD45 B
- I
cells O
. O

Stimulation O
of O
[ O
3H O
] O
PA O
production O
upon O
CD3 B
cross O
- O
linking O
was O
77 O
% O
lower O
in O
permeabilized O
CD45 B
- I
cells O
than O
in O
CD45 B
+ I
cells O
, O
consistent O
with O
the O
reduced O
activity O
of O
p59fyn B
in O
CD45 B
- I
cells O
. O

Fenoldopam O
, O
a O
dopamine B
receptor I
agonist O
, O
has O
been O
shown O
, O
in O
animal O
experiments O
, O
to O
improve O
renal O
perfusion O
. O

The O
resulting O
R B
protein I
terminates O
five O
codons O
downstream O
of O
the O
frameshift O
site O
at O
the O
V B
protein I
stop O
codon O
. O

The O
resulting O
R B
protein I
terminates O
five O
codons O
downstream O
of O
the O
frameshift O
site O
at O
the O
V B
protein I
stop O
codon O
. O

The O
PSD2 B
gene I
was O
heterologously O
expressed O
by O
infection O
of O
Sf O
- O
9 O
insect O
cells O
with O
recombinant O
baculovirus O
, O
resulting O
in O
a O
10 O
- O
fold O
increase O
in O
PSD B
activity O
. O

Co O
- O
transfection O
of O
a O
tat B
expressing O
plasmid O
with O
these O
viruses O
containing O
the O
tat B
ORF I
mutations O
resulted O
in O
higher O
levels O
of O
virus O
production O
demonstrating O
that O
the O
effects O
of O
both O
mutants O
are O
tat B
specific O
. O

We O
also O
show O
by O
immunogold O
electron O
microscopy O
immunocytochemistry O
that O
amphiphysin B
I I
is O
localized O
in O
the O
nerve O
terminal O
cytomatrix O
and O
is O
partially O
associated O
with O
endocytic O
intermediates O
. O

The O
H2 B
receptor I
antagonists O
and O
sucralfate O
cost O
about O
the O
same O
and O
have O
few O
side O
effects O
. O

The O
normal O
cell O
cycle O
is O
regulated O
by O
several O
molecules O
, O
such O
as O
the O
tumor B
- I
suppressor I
protein I
pRb I
, O
the O
G1 B
cyclins I
, O
the O
cyclin B
- I
dependent I
kinases I
, O
and O
their O
inhibitors O
. O

For O
the O
5HT5A B
receptor I
the O
addition O
of O
yohimbine O
resulted O
in O
a O
similar O
but O
smaller O
effect O
. O

Phosphorylation O
of O
myosin B
- I
binding I
subunit I
( O
MBS B
) O
of O
myosin B
phosphatase I
by O
Rho B
- I
kinase I
in O
vivo O
. O

Since O
RCC1p B
acts O
as O
GNRP B
for O
Ran B
, O
a O
small B
nuclear I
GTPase I
of O
the O
ras B
superfamily I
, O
we O
have O
identified O
two O
homologs O
of O
Ran B
in O
S O
. O
cerevisiae O
( O
CNR1 B
and O
CNR2 B
) O
. O

The O
two O
ParA B
proteins I
that O
are O
produced O
as O
a O
result O
of O
independent O
translation O
initiation O
at O
two O
different O
start O
codons O
within O
the O
same O
open O
reading O
frame O
were O
overexpressed O
in O
Escherichia O
coli O
and O
partially O
purified O
. O

Creatine B
kinase I
release O
after O
hepatic O
artery O
embolization O
in O
patients O
with O
carcinoid O
tumors O
. O

Antidepressant O
- O
like O
properties O
of O
some O
serotonin B
receptor I
ligands O
and O
calcium O
channel O
antagonists O
measured O
with O
the O
forced O
swimming O
test O
in O
mice O
. O

The O
expression O
of O
the O
yam8 B
( I
+ I
) I
cDNA I
in O
the O
mid1 B
mutant I
cells O
partially O
remediated O
the O
mid O
phenotype O
and O
resulted O
in O
a O
slight O
increase O
in O
Ca O
( O
2 O
+ O
) O
uptake O
activity O
. O

Contrary O
to O
expectations O
, O
we O
find O
a O
relatively O
high O
level O
of O
variation O
in O
the O
stripe B
2 I
enhancer O
region O
, O
including O
point O
substitutions O
and O
insertion O
/ O
deletions O
in O
binding O
sites O
, O
and O
a O
comparable O
level O
of O
variation O
in O
the O
other O
noncoding O
regions O
. O

They O
suggest O
that O
decreased O
steady O
- O
state O
levels O
of O
IME1 B
and O
IME2 B
mRNA I
were O
not O
merely O
the O
result O
of O
non O
- O
specific O
adverse O
affects O
on O
nucleic O
acid O
metabolism O
caused O
by O
the O
yvh1 B
disruption O
. O

We O
remain O
convinced O
that O
antilymphocyte B
globulin I
( O
ALG B
) O
is O
a O
potent O
immunosuppressive O
agent O
in O
humans O
. O

When O
transiently O
transfected O
into O
K562 O
cells O
, O
this O
Lg B
genomic O
clone O
is O
actively O
transcribed O
, O
suggesting O
that O
, O
although O
it O
possesses O
the O
characteristics O
of O
a O
processed O
pseudogene O
, O
it O
is O
likely O
to O
correspond O
to O
the O
gene O
encoding O
this O
new O
ferritin B
subunit I
. O

The O
Cili B
- I
2 I
sequences I
possess O
similarity O
to O
the O
RNaseH B
domain I
of O
Lian B
- O
Aa1 B
, O
a O
mosquito B
non I
- I
LTR I
retrotransposon I
. O

Protein B
C I
deficiency O
or O
protein B
S I
deficiency O
was O
the O
only O
identified O
risk O
factor O
for O
5 O
. O
4 O
% O
( O
2 O
patients O
) O
and O
13 O
. O
5 O
% O
( O
5 O
patients O
) O
, O
respectively O
, O
of O
these O
37 O
children O
. O

Protein B
C I
deficiency O
or O
protein B
S I
deficiency O
was O
the O
only O
identified O
risk O
factor O
for O
5 O
. O
4 O
% O
( O
2 O
patients O
) O
and O
13 O
. O
5 O
% O
( O
5 O
patients O
) O
, O
respectively O
, O
of O
these O
37 O
children O
. O

Conserved O
and O
distinct O
roles O
of O
kreisler B
in O
regulation O
of O
the O
paralogous O
Hoxa3 B
and O
Hoxb3 B
genes I
. O

Among O
these O
360 O
ZFPs B
, O
a O
novel O
ZFP B
cDNA I
named O
HFHZ B
( O
human B
fetal I
heart I
ZFP I
) O
with O
sequence O
homology O
to O
a O
Kruppel B
- I
associated I
box I
( O
KRAB B
) O
was O
identified O
. O

The O
m7GpppN O
cap O
structure O
of O
eukaryotic O
mRNA O
is O
formed O
cotranscriptionally O
by O
the O
sequential O
action O
of O
three O
enzymes O
: O
RNA B
triphosphatase I
, O
RNA B
guanylyltransferase I
, O
and O
RNA B
( I
guanine I
- I
7 I
) I
- I
methyltransferase I
. O

The O
m7GpppN O
cap O
structure O
of O
eukaryotic O
mRNA O
is O
formed O
cotranscriptionally O
by O
the O
sequential O
action O
of O
three O
enzymes O
: O
RNA B
triphosphatase I
, O
RNA B
guanylyltransferase I
, O
and O
RNA B
( I
guanine I
- I
7 I
) I
- I
methyltransferase I
. O

Mutations O
in O
the O
VPS45 B
gene I
, O
a O
SEC1 B
homologue O
, O
result O
in O
vacuolar O
protein O
sorting O
defects O
and O
accumulation O
of O
membrane O
vesicles O
. O

In O
acute O
- O
phase O
livers O
, O
we O
observed O
a O
dramatic O
reduction O
in O
HNF B
- I
3 I
alpha I
expression O
which O
correlates O
with O
a O
decrease O
in O
the O
expression O
of O
its O
target O
gene O
, O
the O
TTR B
gene I
. O

Sequence O
analysis O
revealed O
that O
the O
MEMA B
protein I
is O
identical O
with O
a O
160 B
kDa I
nuclear I
' I
domain I
rich I
in I
serines I
' I
( I
DRS I
) I
protein I
occurring O
free O
in O
the O
nucleoplasm O
and O
in O
U2 B
- I
ribonucleoprotein I
structures I
. O

Here O
we O
present O
evidence O
that O
the O
distal O
half O
( O
Stem O
2 O
) O
of O
the O
conserved O
base O
- O
paired O
stem O
structure O
found O
in O
all O
hY B
RNAs I
also O
plays O
a O
critical O
role O
in O
the O
export O
process O
. O

We O
propose O
that O
CTS1 B
and I
CTS2 I
of I
Ci I
are O
members O
of O
two O
distinct O
classes O
of O
fungal B
chitinases I
, O
an O
observation O
not O
previously O
reported O
for O
a O
single O
fungus O
. O

The O
HiNF B
- I
D I
( O
CDP B
/ O
cut B
) O
complex O
with O
the O
H4 B
promoter I
is O
immunoreactive O
with O
antibodies O
against O
CDP B
/ O
cut B
and O
pRB B
but O
not O
p107 B
, O
whereas O
the O
CDP B
/ O
cut B
complex O
with O
a O
nonhistone O
promoter O
( O
gp91 B
- O
phox B
) O
reacts O
only O
with O
CDP B
and O
p107 B
antibodies O
. O

Sak B
kinase I
gene O
structure O
and O
transcriptional O
regulation O
. O

These O
data O
reveal O
a O
complex O
network O
of O
interactions O
between O
GTPases B
in O
the O
ARF B
family I
and O
their O
effectors O
and O
reveal O
a O
potential O
for O
cross O
- O
talk O
not O
demonstrated O
previously O
. O

Hypomorphic O
dSLBP B
alleles I
support O
zygotic O
development O
but O
cause O
female O
sterility O
. O

Protein B
cHMGI I
binds O
preferentially O
to O
AT O
- O
rich O
DNA O
with O
a O
half O
- O
saturation O
value O
of O
1 O
. O
1 O
nM O
. O

Polarised O
expression O
of O
human O
intestinal O
N B
- I
benzoyl I
- I
L I
- I
tyrosyl I
- I
p I
- I
aminobenzoic I
acid I
hydrolase I
( O
human B
meprin I
) O
alpha O
and O
beta O
subunits O
in O
Madin O
- O
Darby O
canine O
kidney O
cells O
. O

Reporter O
gene O
expression O
analyses O
indicate O
that O
both O
WASP B
promoters I
show O
high O
levels O
of O
expression O
in O
different O
hematopoietic O
cell O
lines O
. O

Furthermore O
, O
strains O
with O
mutant B
RPM1 I
genes I
also O
accumulate O
precursor B
Rpm1r I
, O
suggesting O
that O
mutations O
in O
either O
gene O
can O
lead O
to O
similar O
biogenesis O
defects O
. O

This O
study O
indicates O
that O
the O
phenotype O
of O
myofibrillar O
disarray O
seen O
in O
HCM O
patients O
which O
harbor O
either O
of O
these O
two O
mutations O
may O
not O
be O
directly O
due O
to O
the O
failure O
of O
the O
mutant B
myosin I
heavy I
chain I
protein I
to O
assemble O
and O
form O
normal O
sarcomeres O
, O
but O
may O
rather O
be O
a O
secondary O
effect O
possibly O
resulting O
from O
the O
chronic O
stress O
of O
decreased O
beta B
MHC I
function O
. O

The O
DNase B
I I
footprint O
extended O
5 O
' O
in O
the O
silencer O
region O
to O
include O
an O
inverted O
repeat O
of O
a O
six O
- O
nucleotide O
motif O
( O
epsilon O
- O
267 O
to O
- O
278 O
bp O
) O
which O
shares O
5 O
of O
6 O
bases O
with O
the O
GATA B
- I
1 I
consensus I
sequence I
. O

A O
study O
in O
vivo O
of O
adrenergic B
receptors I
in O
the O
rectum O
and O
in O
the O
internal O
and O
sphincter O
of O
the O
cat O
. O

A O
2 O
kb O
transcript O
was O
isolated O
from O
brain O
that O
encodes O
a O
approximately O
57 O
kDa O
protein O
; O
the O
predicted O
protein O
contains O
the O
known O
N B
- I
terminal I
Ets I
domain I
of O
PE1 B
and O
a O
novel O
C O
- O
terminal O
domain O
with O
signficant O
homology O
to O
murine B
ERF I
. O

However O
, O
the O
signaling O
cascade O
utilized O
by O
the O
urokinase B
receptor I
is O
only O
incompletely O
understood O
. O

Yeast O
mutants O
lacking O
a O
functional O
NOP1 B
gene I
can O
be O
complemented O
by O
human B
fibrillarin I
but O
are O
temperature O
sensitive O
for O
growth O
and O
impaired O
in O
pre O
- O
rRNA O
processing O
. O

Yeast O
mutants O
lacking O
a O
functional O
NOP1 B
gene I
can O
be O
complemented O
by O
human B
fibrillarin I
but O
are O
temperature O
sensitive O
for O
growth O
and O
impaired O
in O
pre O
- O
rRNA O
processing O
. O

The O
activity O
of O
the O
EGF B
receptor I
promoter I
can O
be O
modulated O
by O
E1A B
protein I
and O
receptor O
RNA O
levels O
increased O
by O
stimulation O
with O
phorbol O
ester O
or O
fetal O
calf O
serum O
. O

Electrophoretic O
mobility O
shift O
assays O
revealed O
that O
Sp1 B
binds O
to O
two O
different O
regions O
in O
the O
proximal O
promoter O
, O
a O
typical O
Sp1 B
site I
located O
at O
( O
- O
38 O
; O
- O
33 O
) O
and O
a O
G O
/ O
C O
- O
rich O
region O
between O
( O
- O
67 O
; O
- O
62 O
) O
. O

Changes O
in O
immunologic O
reactivity O
in O
subjects O
receiving O
transfer B
factor I
could O
not O
be O
distinguished O
from O
those O
in O
subjects O
receiving O
placebo O
. O

The O
LTR O
- O
binding O
activities O
of O
VBP B
, O
a1 B
/ I
EBP I
, O
and O
B B
- I
cell I
nuclear I
extract I
protein I
were O
compared O
and O
mapped O
by O
gel O
shift O
, O
DNase B
I I
footprinting O
, O
and O
methylation O
interference O
assays O
. O

These O
results O
support O
a O
model O
in O
which O
p53 B
protein I
contributes O
to O
the O
maintenance O
of O
genomic O
integrity O
through O
recombinational O
repair O
. O

The O
U14 B
genes I
of O
mouse O
as O
well O
as O
rat O
, O
hamster O
, O
human O
, O
Xenopus O
and O
trout O
are O
encoded O
within O
introns O
of O
the O
constitutively O
expressed O
70 B
- I
kDa I
- I
cognate I
- I
heat I
- I
shock I
protein I
gene I
( O
hsc70 B
) O
. O

Expression O
of O
human B
RACK1 I
efficiently O
relieves O
E1A B
- O
mediated O
growth O
inhibition O
in O
HF7c O
and O
protects O
human O
tumor O
cells O
from O
E1A B
- O
induced O
apoptosis O
. O

In O
all O
cells O
, O
the O
accumulation O
of O
high O
Dsg B
protein I
levels O
required O
calcium O
and O
was O
not O
observed O
in O
low O
calcium O
( O
0 O
. O
05 O
- O
0 O
. O
07 O
mM O
) O
media O
. O

We O
observed O
abundant O
levels O
of O
Rev B
- O
erbA B
alpha I
mRNA O
in O
dividing O
C2C12 O
myoblasts O
, O
which O
were O
suppressed O
when O
the O
cells O
differentiated O
into O
postmitotic O
multinucleated O
myotubes O
. O

We O
have O
followed O
37 O
phenytoin O
- O
treated O
patients O
with O
reduced O
serum B
IgA I
concentrations O
for O
2 O
- O
7 O
years O
. O

The O
binding O
of O
PH B
domains I
to O
Gbetagamma B
was O
inhibited O
by O
preincubation O
of O
Gbetagamma B
with O
the O
GDP O
- O
bound O
but O
not O
the O
GTP O
- O
bound O
form O
of O
Gialpha B
. O

A O
strong O
trithorax B
binding I
site I
was O
found O
at O
the O
cytological O
location O
of O
the O
fork B
head I
gene I
, O
a O
region O
- O
specific O
homeotic B
gene I
not O
located O
within O
a O
homeotic B
complex I
. O

A O
strong O
trithorax B
binding I
site I
was O
found O
at O
the O
cytological O
location O
of O
the O
fork B
head I
gene I
, O
a O
region O
- O
specific O
homeotic B
gene I
not O
located O
within O
a O
homeotic B
complex I
. O

Protein B
kinase I
A I
- I
Ialpha I
subunit O
- O
directed O
antisense O
inhibition O
of O
ovarian O
cancer O
cell O
growth O
: O
crosstalk O
with O
tyrosine B
kinase I
signaling O
pathway O
. O

Because O
the O
DPPD B
gene I
is O
not O
present O
in O
non O
- O
tuberculous O
bacilli O
, O
these O
results O
suggest O
that O
this O
molecule O
can O
be O
an O
additional O
tool O
for O
a O
more O
specific O
diagnosis O
of O
tuberculosis O
. O

Furthermore O
, O
we O
demonstrated O
that O
Galpha11 B
Q209L I
stimulated O
Src B
family I
kinase O
activity O
and O
induced O
tyrosine O
phosphorylation O
of O
several O
proteins O
in O
HEK O
- O
293 O
cells O
. O

Furthermore O
, O
we O
demonstrated O
that O
Galpha11 B
Q209L I
stimulated O
Src B
family I
kinase O
activity O
and O
induced O
tyrosine O
phosphorylation O
of O
several O
proteins O
in O
HEK O
- O
293 O
cells O
. O

Sp1 B
binds O
two O
sites O
in O
the O
CD11c B
promoter I
in O
vivo O
specifically O
in O
myeloid O
cells O
and O
cooperates O
with O
AP1 B
to O
activate O
transcription O
. O

Naltrexone O
hydrochloride O
is O
a O
synthetic O
opioid B
receptor I
antagonist O
recently O
used O
in O
efforts O
to O
provide O
rapid O
opioid O
detoxification O
. O

TRAF2 B
is O
known O
to O
associate O
with O
TRADD B
, O
and O
expression O
of O
a O
dominant O
- O
negative O
N O
- O
terminal O
deletion O
TRAF2 B
mutant I
was O
found O
to O
partially O
inhibit O
LMP1 B
- O
induced O
JNK B
activation O
in O
293 O
cells O
. O

Botulinum B
toxin I
: O
preferred O
treatment O
for O
hemifacial O
spasm O
. O

Angiotensin B
II I
induces O
nuclear B
factor I
( I
NF I
) I
- I
kappaB1 I
isoforms I
to O
bind O
the O
angiotensinogen B
gene I
acute O
- O
phase O
response O
element O
: O
a O
stimulus O
- O
specific O
pathway O
for O
NF B
- I
kappaB I
activation O
. O

Angiotensin B
II I
induces O
nuclear B
factor I
( I
NF I
) I
- I
kappaB1 I
isoforms I
to O
bind O
the O
angiotensinogen B
gene I
acute O
- O
phase O
response O
element O
: O
a O
stimulus O
- O
specific O
pathway O
for O
NF B
- I
kappaB I
activation O
. O

Factor B
VIII I
procoagulant O
activity O
, O
antigen O
concentration O
and O
von B
Willebrand I
activity O
as O
ristocetin B
cofactor I
were O
determined O
several O
times O
in O
10 O
patients O
with O
DIC O
. O

Factor B
VIII I
procoagulant O
activity O
, O
antigen O
concentration O
and O
von B
Willebrand I
activity O
as O
ristocetin B
cofactor I
were O
determined O
several O
times O
in O
10 O
patients O
with O
DIC O
. O

Factor B
VIII I
procoagulant O
activity O
, O
antigen O
concentration O
and O
von B
Willebrand I
activity O
as O
ristocetin B
cofactor I
were O
determined O
several O
times O
in O
10 O
patients O
with O
DIC O
. O

The O
git1 B
, O
git3 B
, O
git5 B
, O
git7 B
, O
git8 B
and O
git10 B
genes I
act O
upstream O
of O
adenylate B
cyclase I
, O
presumably O
encoding O
an O
adenylate B
cyclase I
activation O
pathway O
. O

The O
git1 B
, O
git3 B
, O
git5 B
, O
git7 B
, O
git8 B
and O
git10 B
genes I
act O
upstream O
of O
adenylate B
cyclase I
, O
presumably O
encoding O
an O
adenylate B
cyclase I
activation O
pathway O
. O

The O
git1 B
, O
git3 B
, O
git5 B
, O
git7 B
, O
git8 B
and O
git10 B
genes I
act O
upstream O
of O
adenylate B
cyclase I
, O
presumably O
encoding O
an O
adenylate B
cyclase I
activation O
pathway O
. O

To O
search O
for O
transcriptional O
regulators O
, O
we O
used O
a O
fragment O
of O
the O
SpHE B
promoter I
containing O
several O
individual O
elements O
instead O
of O
the O
conventional O
bait O
that O
contains O
a O
multimerized O
cis O
element O
. O

These O
data O
support O
a O
possible O
biological O
significance O
of O
the O
frameshift O
to O
occur O
at O
this O
position O
of O
the O
large O
overlap O
by O
including O
the O
putative O
RNA O
template O
- O
binding O
site O
of O
the O
PLRV B
replicase I
in O
the O
ORF2a B
/ I
ORF2b I
transframe I
protein I
. O

The O
mRNAs O
of O
the O
GRF B
genes I
are O
encoded O
by O
six O
exons O
interrupted O
by O
five O
introns O
. O

Plasma B
secretin I
, O
pancreozymin B
, O
and O
somatostatin B
- I
like I
hormone I
in O
chronic O
renal O
failure O
patients O
. O

DNase B
I I
genomic O
footprinting O
revealed O
that O
the O
c B
- I
Myb I
site I
is O
occupied O
in O
a O
tissue O
- O
specific O
fashion O
in O
vivo O
. O

Minor O
differences O
were O
noted O
with O
latamoxef O
producing O
mild O
persistant O
elevation O
of O
prothrombin B
time O
( O
0 O
. O
7 O
second O
) O
associated O
with O
depression O
of O
factor B
II I
and O
factor B
VII I
. O

Minor O
differences O
were O
noted O
with O
latamoxef O
producing O
mild O
persistant O
elevation O
of O
prothrombin B
time O
( O
0 O
. O
7 O
second O
) O
associated O
with O
depression O
of O
factor B
II I
and O
factor B
VII I
. O

The O
U17 B
/ O
U16 B
and O
the O
U16 B
+ I
gene I
products I
transactivated O
the O
HIV B
LTR I
. O

Interestingly O
, O
the O
interaction O
of O
ZAP B
- I
70 I
with O
the O
motif O
was O
dependent O
on O
the O
presence O
of O
both O
ZAP B
- I
70 I
SH2 B
domains I
and O
both O
of O
the O
tyrosine O
residues O
in O
the O
motif O
, O
suggesting O
that O
ZAP B
- I
70 I
interacts O
with O
two O
phosphotyrosine O
residues O
and O
that O
the O
binding O
of O
the O
two O
SH2 B
domains I
is O
cooperative O
. O

Interestingly O
, O
the O
interaction O
of O
ZAP B
- I
70 I
with O
the O
motif O
was O
dependent O
on O
the O
presence O
of O
both O
ZAP B
- I
70 I
SH2 B
domains I
and O
both O
of O
the O
tyrosine O
residues O
in O
the O
motif O
, O
suggesting O
that O
ZAP B
- I
70 I
interacts O
with O
two O
phosphotyrosine O
residues O
and O
that O
the O
binding O
of O
the O
two O
SH2 B
domains I
is O
cooperative O
. O

Pokeweed B
mitogen I
( O
PWM B
) O
or O
anti B
- I
CD3 I
significantly O
increases O
c B
- I
jun I
messenger I
RNA I
( I
mRNA I
) I
levels O
in O
T O
cells O
. O

p230 B
also O
includes O
the O
sequence O
ESLALEELEL O
( O
amino O
acids O
538 O
- O
546 O
) O
, O
a O
motif O
found O
in O
the O
granin B
family I
of O
acidic O
proteins O
present O
in O
secretory O
granules O
of O
neuroendocrine O
cells O
. O

The O
human O
cDNA O
was O
used O
to O
demonstrate O
that O
tumor B
necrosis I
factor I
- I
alpha I
could O
rapidly O
stimulate O
MARCKS B
gene I
transcription O
in O
the O
human O
promyelocytic O
leukemia O
cell O
line O
HL60 O
. O

RESULTS O
: O
Using O
information O
in O
the O
dbEST O
database O
of O
expressed O
sequence O
tags O
, O
we O
isolated O
an O
Arabidopsis O
thaliana O
gene O
( O
GCR1 B
) O
that O
encodes O
a O
protein O
with O
seven O
predicted O
membrane O
- O
spanning O
domains O
and O
other O
features O
characteristic O
of O
7TM B
receptors I
. O

A O
cause O
of O
increase O
of O
alkaline B
phosphatase I
in O
children O

The O
integrity O
of O
the O
cDNA O
sequence O
was O
confirmed O
by O
analysis O
of O
several O
overlapping O
genomic O
clones O
that O
span O
the O
GAR1 B
gene I
. O

An O
unusual O
cysteine O
triplet O
conserved O
in O
the O
sequences O
of O
TB B
domains I
is O
localized O
to O
the O
hydrophobic O
core O
, O
at O
the O
C O
- O
terminus O
of O
an O
alpha O
- O
helix O
. O

The O
Rlm1 B
protein I
, O
a O
member O
of O
the O
MADS B
box I
family I
of O
transcription O
factors O
, O
functions O
downstream O
of O
Mpk1 B
in O
the O
pathway O
. O

The O
observed O
phenotypes O
may O
be O
explained O
by O
( O
i O
) O
a O
selective O
disruption O
of O
very B
- I
low I
- I
density I
lipoprotein I
secretion O
due O
to O
decreased O
expression O
of O
genes O
encoding O
apolipoprotein B
B I
and O
microsomal B
triglyceride I
transfer I
protein I
, O
( O
ii O
) O
an O
increase O
in O
hepatic O
cholesterol O
uptake O
due O
to O
increased O
expression O
of O
the O
major O
high B
- I
density I
lipoprotein I
receptor I
, O
scavenger B
receptor I
BI I
, O
and O
( O
iii O
) O
a O
decrease O
in O
bile O
acid O
uptake O
to O
the O
liver O
due O
to O
down O
- O
regulation O
of O
the O
major O
basolateral B
bile I
acid I
transporters I
sodium I

The O
N O
- O
terminal O
small O
segment O
of O
yeast B
TAF145 I
( O
yTAF145 B
) O
binds O
to O
TBP B
and O
thereby O
inhibits O
TBP B
function O
. O

Southern O
analysis O
on O
genomic O
DNA O
isolated O
from O
tissues O
and O
cell O
lines O
from O
several O
mouse O
strains O
using O
mCD22 B
cDNA I
demonstrated O
that O
the O
Cd22 B
locus I
encoding O
mCD22 B
is O
a O
single O
copy O
gene O
of O
< O
or O
= O
30 O
kb O
. O

Southern O
analysis O
on O
genomic O
DNA O
isolated O
from O
tissues O
and O
cell O
lines O
from O
several O
mouse O
strains O
using O
mCD22 B
cDNA I
demonstrated O
that O
the O
Cd22 B
locus I
encoding O
mCD22 B
is O
a O
single O
copy O
gene O
of O
< O
or O
= O
30 O
kb O
. O

Further O
, O
they O
are O
consistent O
with O
the O
suggestion O
that O
sites O
homologous O
to O
the O
CAR1 B
URS I
may O
be O
situated O
in O
the O
5 O
' O
- O
flanking O
regions O
of O
multiple O
unrelated O
yeast O
genes O
. O

Ethylene O
is O
involved O
in O
endosperm O
rupture O
and O
high O
- O
level O
betaGLU B
I I
expression O
; O
but O
, O
it O
does O
not O
affect O
the O
spatial O
and O
temporal O
pattern O
of O
betaGLU B
I I
expression O
. O

Ethylene O
is O
involved O
in O
endosperm O
rupture O
and O
high O
- O
level O
betaGLU B
I I
expression O
; O
but O
, O
it O
does O
not O
affect O
the O
spatial O
and O
temporal O
pattern O
of O
betaGLU B
I I
expression O
. O

We O
have O
used O
mutation O
- O
directed O
chemical O
cross O
- O
linking O
with O
bis O
( O
sulfosuccinimidyl O
) O
suberate O
( O
BS3 O
) O
to O
investigate O
the O
architecture O
of O
the O
gp41 B
oligomer I
. O

Northern O
analyses O
of O
RNAs O
from O
mouse O
tissues O
and O
cell O
lines O
indicated O
that O
p11 B
mRNA I
levels O
vary O
widely O
. O

To O
determine O
whether O
vanadate O
could O
inhibit O
PEPCK B
gene I
transcription O
, O
a O
series O
of O
chimeric O
genes O
containing O
several O
deletions O
in O
the O
P B
- I
enolypyruvate I
carboxykinase I
promoter I
between O
- O
550 O
and O
- O
68 O
was O
linked O
to O
the O
structural O
genes O
for O
either O
amino B
- I
3 I
- I
glycosyl I
phosphotransferase I
( O
neo B
) O
or O
chloramphenicol B
acetyltransferase I
and O
introduced O
into O
hepatoma O
cells O
using O
three O
methods O
: O
( O
a O
) O
infection O
with O
a O
Moloney O
murine O
leukemia O
virus O
- O
based O
retrovirus O
, O
( O
b O

To O
determine O
whether O
vanadate O
could O
inhibit O
PEPCK B
gene I
transcription O
, O
a O
series O
of O
chimeric O
genes O
containing O
several O
deletions O
in O
the O
P B
- I
enolypyruvate I
carboxykinase I
promoter I
between O
- O
550 O
and O
- O
68 O
was O
linked O
to O
the O
structural O
genes O
for O
either O
amino B
- I
3 I
- I
glycosyl I
phosphotransferase I
( O
neo B
) O
or O
chloramphenicol B
acetyltransferase I
and O
introduced O
into O
hepatoma O
cells O
using O
three O
methods O
: O
( O
a O
) O
infection O
with O
a O
Moloney O
murine O
leukemia O
virus O
- O
based O
retrovirus O
, O
( O
b O

) O
transfection O
and O
stable O
selection O
for O
neo B
expression O
, O
or O
( O
c O
) O
transient O
expression O
of O
chloroamphenicol B
acetyltransferase I
. O

Because O
the O
human B
Antp I
TATAA I
binding I
protein I
is O
expressed O
in O
both O
lymphoid O
and O
non O
- O
lymphoid O
cells O
, O
we O
suggest O
that O
this O
homeobox B
gene I
has O
evolved O
a O
more O
general O
transcriptional O
regulatory O
function O
in O
higher O
eukaryotic O
cells O
. O

The O
pyrR B
and O
pyrP B
genes I
encoded O
polypeptides O
with O
calculated O
molecular O
masses O
of O
19 O
. O
9 O
and O
45 O
. O
2 O
kDa O
, O
respectively O
. O

The O
RAT3 B
gene I
encodes O
an O
1157 O
- O
amino O
acid O
protein O
without O
similarity O
to O
other O
known O
proteins O
. O

Demonstration O
of O
tissue O
lesions O
after O
intramuscular O
injection O
by O
determination O
of O
creatine B
kinase I
in O
blood O

Most O
strains O
( O
95 O
% O
) O
of O
S O
. O
lugdunensis O
produced O
a O
delta B
hemolysin I
like O
that O
seen O
with O
nine O
other O
species O
of O
CNS O
. O

Mutations O
within O
conserved O
region O
2 O
( O
CR2 O
) O
of O
E1A B
that O
inhibit O
the O
binding O
of O
E1A B
to O
the O
retinoblastoma B
gene I
product I
( O
pRb B
) O
further O
enhanced O
the O
stimulation O
of O
transcription O
from O
the O
PEPCK B
promoter I
by O
2 O
3 O
- O
fold O
compared O
with O
wild B
type I
E1A I
. O

Several O
of O
the O
exon O
boundaries O
correspond O
to O
the O
boundaries O
of O
functional O
domains O
in O
the O
p55 B
protein I
. O

We O
used O
stored O
plasma O
samples O
from O
409 O
patients O
in O
the O
National O
Institute O
of O
Neurological O
Diseases O
and O
Stroke O
( O
NINDS O
) O
tissue B
plasminogen I
activator I
( O
t B
- I
PA I
) O
Stroke O
Trial O
to O
examine O
the O
relationship O
between O
an O
apolipoprotein B
( I
Apo I
) I
E2 I
or O
an O
Apo B
E4 I
phenotype O
and O
a O
favorable O
outcome O
3 O
months O
after O
stroke O
, O
the O
risk O
of O
intracerebral O
hemorrhage O
, O
and O
the O
response O
to O
intravenous O
t B
- I
PA I
therapy O
. O

Taken O
together O
, O
these O
results O
indicate O
that O
MAP B
kinase I
stimulates O
the O
hPL B
- I
B I
enhancer I
by O
an O
NF B
- I
IL I
- I
6 I
- O
dependent O
pathway O
. O

Comparison O
of O
immunoassay O
kits O
for O
detection O
of O
staphylococcal B
enterotoxins I
produced O
by O
Staphylococcus O
aureus O

The O
amino O
acid O
sequence O
alignment O
of O
TC B
II I
with O
that O
of O
other O
Cbl B
binding I
proteins I
( O
rat B
intrinsic I
factor I
, O
human B
transcobalamin I
I I
and O
porcine B
haptocorrin I
) O
revealed O
only O
33 O
% O
overall O
homology O
. O

The O
amino O
acid O
sequence O
alignment O
of O
TC B
II I
with O
that O
of O
other O
Cbl B
binding I
proteins I
( O
rat B
intrinsic I
factor I
, O
human B
transcobalamin I
I I
and O
porcine B
haptocorrin I
) O
revealed O
only O
33 O
% O
overall O
homology O
. O

Abrogation O
of O
p53 B
function O
by O
E6 B
resulted O
in O
an O
increase O
in O
the O
spontaneous O
mutation O
frequencies O
at O
the O
heterozygous O
thymidine B
kinase I
( O
TK B
) O
locus O
but O
not O
at O
the O
hemizygous O
hypoxanthine B
phosphoribosyl I
transferase I
( O
HPRT B
) O
locus O
. O

In O
view O
of O
the O
presence O
of O
SECIS O
elements O
in O
the O
open O
reading O
frames O
( O
ORFs O
) O
of O
bacterial B
selenoproteins I
, O
we O
examine O
the O
effects O
in O
the O
type B
1 I
deiodinase I
of O
extending O
the O
ORF O
into O
the O
SECIS O
element O
, O
and O
find O
that O
this O
dramatically O
inhibits O
SECIS O
function O
. O

However O
, O
while O
the O
sequence O
similarity O
between O
the O
membrane O
exons O
of O
avian B
mIgY I
and O
mammalian B
mIgG I
and I
IgE I
is O
striking O
, O
the O
overall O
similarity O
with O
Xenopus B
mIgY I
is O
very O
low O
. O

However O
, O
while O
the O
sequence O
similarity O
between O
the O
membrane O
exons O
of O
avian B
mIgY I
and O
mammalian B
mIgG I
and I
IgE I
is O
striking O
, O
the O
overall O
similarity O
with O
Xenopus B
mIgY I
is O
very O
low O
. O

The O
Nostoc O
petBD B
genes I
are O
not O
closely O
linked O
to O
the O
psbB B
gene I
( O
encoding O
the O
51 O
- O
kDa O
photosystem B
II I
polypeptide I
) O
and O
do O
not O
contain O
introns O
as O
do O
the O
closely O
related O
chloroplast O
genes O
. O

The O
Nostoc O
petBD B
genes I
are O
not O
closely O
linked O
to O
the O
psbB B
gene I
( O
encoding O
the O
51 O
- O
kDa O
photosystem B
II I
polypeptide I
) O
and O
do O
not O
contain O
introns O
as O
do O
the O
closely O
related O
chloroplast O
genes O
. O

We O
propose O
a O
model O
in O
which O
Sro7 B
function O
is O
involved O
in O
the O
targeting O
of O
the O
myosin B
proteins I
to O
their O
intrinsic O
pathways O
. O

These O
similarities O
suggest O
that O
these O
E2 B
proteins I
are O
structurally O
and O
evolutionarily O
related O
. O

When O
two O
- O
dimensional O
polyacrylamide O
gel O
electrophoretic O
patterns O
of O
[ O
35S O
] O
methionine O
- O
labeled O
proteins O
secreted O
from O
cells O
infected O
with O
parental O
and O
recombinant O
viruses O
were O
compared O
, O
a O
spot O
missing O
from O
the O
latter O
corresponded O
in O
molecular O
weigh O
and O
isoelectric O
point O
with O
that O
predicted O
from O
the O
N1L B
ORF I
. O

Secretory B
IgA I
and O
serum B
immunoglobulins I
as O
indices O
of O
the O
local O
immunity O
of O
the O
intestinal O
mucosa O
in O
acute O
leukemias O

Secretory B
IgA I
and O
serum B
immunoglobulins I
as O
indices O
of O
the O
local O
immunity O
of O
the O
intestinal O
mucosa O
in O
acute O
leukemias O

This O
region O
of O
hsp90 B
mediates O
ATP O
- O
independent O
chaperone O
activity O
, O
overlaps O
the O
hsp90 B
dimerization I
domain I
, O
and O
includes O
structural O
elements O
important O
for O
steroid B
receptor I
interaction O
. O

The O
cDNA O
segment O
is O
flanked O
by O
the O
immunoglobulin B
gene I
recombination I
signal I
sequences I
so O
that O
the O
cDNA O
segment O
can O
invert O
and O
the O
human B
IL I
- I
2R I
L I
chain I
is O
subsequently O
expressed O
under O
the O
control O
of O
the O
SV40 B
promoter I
. O

The O
previously O
described O
enhanced O
translation O
of O
spinach O
L12 B
mRNA I
from O
its O
two O
tandem O
AUG O
codons O
and O
the O
two O
functional O
rpl12 B
genes I
in O
Arabidopsis O
probably O
provide O
two O
mechanisms O
for O
generating O
the O
four O
copies O
of O
L12 B
/ I
chloroplast I
ribosome I
, O
qualitatively O
different O
from O
those O
attempted O
in O
eubacteria O
. O

The O
previously O
described O
enhanced O
translation O
of O
spinach O
L12 B
mRNA I
from O
its O
two O
tandem O
AUG O
codons O
and O
the O
two O
functional O
rpl12 B
genes I
in O
Arabidopsis O
probably O
provide O
two O
mechanisms O
for O
generating O
the O
four O
copies O
of O
L12 B
/ I
chloroplast I
ribosome I
, O
qualitatively O
different O
from O
those O
attempted O
in O
eubacteria O
. O

Nucleotide O
sequence O
analysis O
revealed O
that O
TAR B
- I
binding I
protein I
is O
very O
similar O
to O
the O
CREB2 B
protein I
. O

DESIGN O
: O
Serum O
aldosterone O
and O
plasma B
renin I
activity O
were O
measured O
supine O
prior O
to O
and O
60 O
, O
90 O
, O
120 O
minutes O
after O
oral O
captopril O
, O
25 O
mg O
. O

We O
have O
found O
that O
the O
expression O
of O
GTPase B
- O
deficient O
mutants O
of O
alpha B
12 I
( O
alpha B
12Q229L I
) O
or O
alpha B
13 I
( O
alpha B
13Q226L I
) O
leads O
to O
robust O
activation O
of O
the O
Jun B
kinase I
/ O
stress B
- I
activated I
protein I
kinase I
( O
JNK B
/ O
SAPK B
) O
pathway O
. O

We O
have O
found O
that O
the O
expression O
of O
GTPase B
- O
deficient O
mutants O
of O
alpha B
12 I
( O
alpha B
12Q229L I
) O
or O
alpha B
13 I
( O
alpha B
13Q226L I
) O
leads O
to O
robust O
activation O
of O
the O
Jun B
kinase I
/ O
stress B
- I
activated I
protein I
kinase I
( O
JNK B
/ O
SAPK B
) O
pathway O
. O

We O
have O
found O
that O
the O
expression O
of O
GTPase B
- O
deficient O
mutants O
of O
alpha B
12 I
( O
alpha B
12Q229L I
) O
or O
alpha B
13 I
( O
alpha B
13Q226L I
) O
leads O
to O
robust O
activation O
of O
the O
Jun B
kinase I
/ O
stress B
- I
activated I
protein I
kinase I
( O
JNK B
/ O
SAPK B
) O
pathway O
. O

We O
have O
found O
that O
the O
expression O
of O
GTPase B
- O
deficient O
mutants O
of O
alpha B
12 I
( O
alpha B
12Q229L I
) O
or O
alpha B
13 I
( O
alpha B
13Q226L I
) O
leads O
to O
robust O
activation O
of O
the O
Jun B
kinase I
/ O
stress B
- I
activated I
protein I
kinase I
( O
JNK B
/ O
SAPK B
) O
pathway O
. O

We O
have O
found O
that O
the O
expression O
of O
GTPase B
- O
deficient O
mutants O
of O
alpha B
12 I
( O
alpha B
12Q229L I
) O
or O
alpha B
13 I
( O
alpha B
13Q226L I
) O
leads O
to O
robust O
activation O
of O
the O
Jun B
kinase I
/ O
stress B
- I
activated I
protein I
kinase I
( O
JNK B
/ O
SAPK B
) O
pathway O
. O

Sp1 B
and O
two O
Sp3 B
isoforms I
were O
detected O
as O
the O
primary O
cellular O
constituents O
of O
DNA O
- O
protein O
complexes O
formed O
with O
the O
NF B
- I
kappaB I
- I
proximal I
site I
. O

Spontaneous O
sensitization O
to O
cross O
- O
reacting O
chemicals O
in O
a O
proportion O
of O
control O
animals O
is O
strongly O
suggested O
, O
somewhat O
akin O
to O
spontaneous O
sensitization O
in O
patients O
with O
anaphylactoid O
reactions O
to O
neuromuscular O
blockers O
on O
first O
exposure O
, O
and O
in O
whom O
IgE B
antibodies I
are O
detected O
. O

This O
may O
account O
, O
at O
least O
in O
part O
, O
for O
the O
ability O
of O
excess O
wt B
p53 I
to O
inhibit O
cell O
proliferation O
and O
to O
interfere O
with O
neoplastic O
processes O
. O

IgG B
and O
IgM B
antibody O
activity O
was O
determined O
by O
adding O
a O
1 O
: O
100 O
dilution O
of O
serum O
to O
plates O
coated O
with O
A60 B
antigen I
. O

We O
also O
show O
that O
p65 B
binds O
to O
these O
targets O
with O
almost O
equal O
affinity O
and O
that O
different O
residues O
have O
variable O
roles O
in O
binding O
different O
kappaB B
targets I
. O

The O
RNase B
MRP I
RNA I
gene I
was O
deleted O
by O
insertional O
replacement O
and O
found O
to O
be O
essential O
for O
cellular O
viability O
, O
indicating O
a O
critical O
nuclear O
role O
for O
RNase B
MRP I
. O

Its O
predicted O
amino O
acid O
sequence O
shows O
extensive O
homology O
to O
those O
of O
Drosophila B
hsp70 I
, O
trout B
hsp70 I
, O
Xenopus B
hsp70 I
, O
yeast B
hsp70 I
, O
and O
some O
homology O
to O
the O
heat B
- I
inducible I
dnaK I
gene I
product I
of O
Escherichia O
coli O
. O

Its O
predicted O
amino O
acid O
sequence O
shows O
extensive O
homology O
to O
those O
of O
Drosophila B
hsp70 I
, O
trout B
hsp70 I
, O
Xenopus B
hsp70 I
, O
yeast B
hsp70 I
, O
and O
some O
homology O
to O
the O
heat B
- I
inducible I
dnaK I
gene I
product I
of O
Escherichia O
coli O
. O

Its O
predicted O
amino O
acid O
sequence O
shows O
extensive O
homology O
to O
those O
of O
Drosophila B
hsp70 I
, O
trout B
hsp70 I
, O
Xenopus B
hsp70 I
, O
yeast B
hsp70 I
, O
and O
some O
homology O
to O
the O
heat B
- I
inducible I
dnaK I
gene I
product I
of O
Escherichia O
coli O
. O

Its O
predicted O
amino O
acid O
sequence O
shows O
extensive O
homology O
to O
those O
of O
Drosophila B
hsp70 I
, O
trout B
hsp70 I
, O
Xenopus B
hsp70 I
, O
yeast B
hsp70 I
, O
and O
some O
homology O
to O
the O
heat B
- I
inducible I
dnaK I
gene I
product I
of O
Escherichia O
coli O
. O

These O
findings O
suggest O
a O
functional O
cross O
- O
talk O
between O
RB B
protein I
and O
p21ras B
, O
which O
balances O
the O
cell O
phenotype O
between O
normal O
and O
transformed O
states O
. O

UDP B
- I
GlcNAc I
: O
alpha B
- I
6 I
- I
D I
- I
mannoside I
beta I
- I
1 I
, I
2 I
- I
N I
- I
acetylglucosaminyltransferase I
II I
( O
GnT B
II I
; O
EC B
2 I
. I
4 I
. I
1 I
. I
143 I
) O
is O
essential O
for O
the O
normal O
assembly O
of O
complex O
Asn O
- O
linked O
glycans O
. O

Three O
subgenomes O
also O
comprised O
15 O
to O
75 O
nucleotides O
derived O
from O
the O
5 O
' O
part O
of O
the O
NS2 B
gene I
. O

Previously O
, O
we O
showed O
that O
the O
APRE O
is O
a O
cytokine O
[ O
tumor B
necrosis I
factor I
- I
alpha I
( O
TNFalpha B
) O
] O
- O
inducible O
enhancer O
by O
binding O
the O
heterodimeric B
nuclear I
factor I
- I
kappaB I
( O
NF B
- I
kappaB I
) O
complex O
Rel B
A I
x O
NF B
- I
kappaB1 I
. O

Finally O
, O
we O
present O
evidence O
that O
fimbrin B
is O
a O
third O
distinct O
plastin B
isoform I
which O
is O
specifically O
expressed O
at O
high O
levels O
in O
the O
small O
intestine O
. O

The O
lemdr1 B
gene I
was O
cloned O
in O
the O
expression O
vector O
pALTNEO O
and O
transfected O
into O
wild O
- O
type O
L O
. O
enriettii O
and O
the O
resulting O
transfected O
cells O
were O
resistant O
to O
vinblastine O
but O
at O
lower O
levels O
than O
in O
the O
selected O
mutant O
cells O
. O

The O
gene O
is O
1 O
, O
139 O
base O
pairs O
( O
bp O
) O
long O
, O
and O
, O
like O
other O
members O
of O
the O
SIG B
family I
, O
the O
beta B
TG I
gene I
is O
divided O
into O
3 O
exons O
. O

Using O
a O
conditional O
- O
lethal O
mutant O
allele O
of O
SUP45 B
( O
sup45 B
- I
2 I
) O
and O
a O
combination O
of O
in O
vivo O
and O
in O
vitro O
approaches O
, O
we O
demonstrate O
that O
the O
product O
of O
the O
SUP45 B
gene I
( O
Sup45p B
or O
eRF1 B
) O
is O
a O
factor O
required O
for O
translation O
termination O
in O
yeast O
. O

In O
addition O
, O
a O
microsatellite O
repeat O
polymorphism O
with O
a O
heterozygosity O
of O
71 O
% O
at O
the O
RET B
locus I
and O
a O
restriction O
fragment O
length O
polymorphism O
with O
a O
heterozygosity O
of O
42 O
% O
detected O
by O
a O
lambda O
clone O
from O
the O
D10S94 B
locus I
have O
been O
developed O
for O
high O
- O
resolution O
genetic O
linkage O
mapping O
and O
predictive O
diagnostic O
testing O
. O

In O
addition O
, O
a O
microsatellite O
repeat O
polymorphism O
with O
a O
heterozygosity O
of O
71 O
% O
at O
the O
RET B
locus I
and O
a O
restriction O
fragment O
length O
polymorphism O
with O
a O
heterozygosity O
of O
42 O
% O
detected O
by O
a O
lambda O
clone O
from O
the O
D10S94 B
locus I
have O
been O
developed O
for O
high O
- O
resolution O
genetic O
linkage O
mapping O
and O
predictive O
diagnostic O
testing O
. O

A O
cDNA O
clone O
corresponding O
to O
the O
putative O
GA B
20 I
- O
oxidase B
genomic O
sequence O
was O
constructed O
with O
the O
reverse O
transcription O
- O
PCR O
method O
, O
and O
the O
identity O
of O
the O
cDNA O
clone O
was O
confirmed O
by O
analyzing O
the O
capability O
of O
the O
fusion O
protein O
expressed O
in O
Escherichia O
coli O
to O
convert O
GA53 B
to O
GA44 B
and O
GA19 B
to O
GA20 B
. O

The O
arrangement O
of O
these O
cutoff O
- O
levels O
leads O
to O
a O
sensitivity O
of O
85 O
% O
at O
a O
specificity O
of O
55 O
% O
for O
Protein B
S100 I
when O
measured O
by O
RIA O
, O
and O
to O
a O
sensitivity O
of O
77 O
% O
at O
a O
specificity O
of O
61 O
% O
when O
measured O
by O
LIA O
. O

To O
understand O
whether O
Shc B
localization O
in O
membrane O
rafts O
is O
sufficient O
to O
regulate O
Shc B
function O
, O
we O
constructed O
a O
Shc B
chimera I
containing O
the O
Ras B
membrane I
localization I
motif I
at O
the O
C O
- O
terminus O
. O

Furthermore O
, O
competitor O
containing O
the O
YY1 B
consensus I
sequence I
competed O
for O
protein B
B I
binding O
, O
whereas O
competitor O
containing O
a O
perfect O
yeast B
ABF I
- I
1 I
consensus I
sequence I
did O
not O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
400 O
WORDS O
) O

A O
segment O
of O
mRNA O
encoding O
the O
leader O
peptide O
of O
the O
CPA1 B
gene I
confers O
repression O
by O
arginine O
on O
a O
heterologous O
yeast O
gene O
transcript O
. O

At O
the O
C O
- O
terminus O
of O
the O
protein O
is O
a O
domain O
that O
contains O
sequences O
very O
similar O
to O
those O
found O
in O
the O
breakpoint O
cluster O
region O
gene O
product O
, O
n B
- I
chimerin I
, O
and O
rho B
GAP I
, O
all O
of O
which O
have O
been O
shown O
to O
possess O
intrinsic O
GAP B
activity O
on O
small B
GTPases I
. O

At O
the O
C O
- O
terminus O
of O
the O
protein O
is O
a O
domain O
that O
contains O
sequences O
very O
similar O
to O
those O
found O
in O
the O
breakpoint O
cluster O
region O
gene O
product O
, O
n B
- I
chimerin I
, O
and O
rho B
GAP I
, O
all O
of O
which O
have O
been O
shown O
to O
possess O
intrinsic O
GAP B
activity O
on O
small B
GTPases I
. O

The O
previously O
described O
four O
sets O
of O
13 O
- O
to O
18 O
- O
base O
- O
pair O
interspersed O
repeat O
elements O
between O
- O
55 O
and O
- O
580 O
provide O
most O
of O
the O
high O
basal O
transcriptional O
strength O
, O
whereas O
the O
arrangement O
of O
further O
upstream O
tandemly O
repeated O
NF1 B
- I
binding I
sites I
may O
contribute O
significantly O
to O
the O
expanded O
biological O
host O
range O
for O
expression O
of O
SCMV B
IE94 I
compared O
with O
HCMV B
IE68 I
. O

The O
previously O
described O
four O
sets O
of O
13 O
- O
to O
18 O
- O
base O
- O
pair O
interspersed O
repeat O
elements O
between O
- O
55 O
and O
- O
580 O
provide O
most O
of O
the O
high O
basal O
transcriptional O
strength O
, O
whereas O
the O
arrangement O
of O
further O
upstream O
tandemly O
repeated O
NF1 B
- I
binding I
sites I
may O
contribute O
significantly O
to O
the O
expanded O
biological O
host O
range O
for O
expression O
of O
SCMV B
IE94 I
compared O
with O
HCMV B
IE68 I
. O

Furthermore O
, O
LB1 B
gene I
mapped O
to O
chromosome O
13q14 O
, O
a O
region O
that O
has O
been O
involved O
as O
a O
chromosomal O
breakpoint O
in O
DLBL O
. O

Neither O
gene O
possesses O
a O
distinct O
transcriptional O
start O
site O
as O
shown O
by O
nuclease B
S1 I
analysis O
. O

The O
variability O
is O
most O
likely O
a O
result O
of O
alternative O
splicing O
of O
exons O
from O
the O
primary O
elastin B
transcripts I
. O

Furthermore O
, O
a O
minor O
start O
site O
was O
localized O
179 O
bp O
upstream O
of O
the O
major O
site O
using O
reverse B
transcriptase I
- O
polymerase O
chain O
reaction O
with O
various O
P1 O
primers O
( O
primer O
walking O
) O
, O
primer O
extension O
, O
and O
cDNA O
cloning O
. O

LY290181 O
appears O
to O
inhibit O
uPA B
promoter I
activation O
by O
blocking O
phorbol O
ester O
- O
stimulated O
binding O
of O
nuclear O
proteins O
to O
the O
uPA B
PEA3 B
/ O
12 O
- O
0 O
- O
tetradecanoylphorbol O
13 O
- O
acetate O
responsive O
element O
( O
TRE O
) O
. O

The O
divergence O
in O
primary O
structure O
between O
the O
sheep O
CRF1 B
and O
the O
other O
mammalian B
CRF1s I
is O
primarily O
localized O
to O
the O
extracellular O
amino O
terminal O
domain O
of O
the O
receptor O
( O
18 O
of O
22 O
divergent O
residues O
, O
ovine O
vs O
human B
CRF1 I
) O
. O

The O
divergence O
in O
primary O
structure O
between O
the O
sheep O
CRF1 B
and O
the O
other O
mammalian B
CRF1s I
is O
primarily O
localized O
to O
the O
extracellular O
amino O
terminal O
domain O
of O
the O
receptor O
( O
18 O
of O
22 O
divergent O
residues O
, O
ovine O
vs O
human B
CRF1 I
) O
. O

We O
then O
demonstrated O
that O
1 O
) O
GAL4 B
- O
REV B
- O
erbA B
alpha I
chimeras O
that O
contain O
the O
' O
AB O
' O
region O
and O
lack O
the O
' O
E O
' O
region O
activated O
transcription O
of O
GAL4 B
response I
elements I
in O
the O
presence O
of O
8 O
- O
Br O
- O
cAMP O
and O
2 O
) O
the O
ligand O
- O
binding O
domain O
( O
LBD O
) O
contains O
an O
active O
transcriptional O
silencer O
. O

The O
Clb5 B
kinase I
, O
which O
promotes O
S O
phase O
, O
remains O
active O
during O
the O
G2 O
- O
phase O
arrest O
of O
cells O
of O
the O
parental O
strain O
, O
but O
its O
activity O
declines O
rapidly O
in O
sim B
mutants I
. O

The O
Clb5 B
kinase I
, O
which O
promotes O
S O
phase O
, O
remains O
active O
during O
the O
G2 O
- O
phase O
arrest O
of O
cells O
of O
the O
parental O
strain O
, O
but O
its O
activity O
declines O
rapidly O
in O
sim B
mutants I
. O

The O
3 O
. O
3 O
- O
fold O
higher O
expression O
in O
the O
fetal O
heart O
than O
in O
the O
adult O
heart O
suggests O
that O
HFHZ B
mRNA I
is O
downregulated O
in O
the O
process O
of O
development O
. O

A O
xylE B
transcriptional I
fusion I
to O
the O
putative O
mxbD B
promoter I
showed O
low O
- O
level O
expression O
in O
wild O
- O
type O
cells O
grown O
on O
one O
- O
carbon O
( O
C1 O
) O
compounds O
and O
no O
detectable O
expression O
in O
cells O
grown O
on O
succinate O
. O

The O
structural O
study O
of O
peptides O
belonging O
to O
the O
terminal O
domains O
of O
histone B
H1 I
can O
be O
considered O
as O
a O
step O
toward O
the O
understanding O
of O
the O
function O
of O
H1 B
in O
chromatin O
. O

A O
point O
mutation O
in O
Galphao B
and O
Galphai1 B
blocks O
interaction O
with O
regulator O
of O
G B
protein I
signaling O
proteins O
. O

Activation O
of O
PKA B
by O
8 O
- O
bromo O
- O
cyclic O
AMP O
or O
forskolin O
, O
and O
inhibition O
of O
PKC B
by O
calphostin O
C O
, O
resulted O
in O
a O
significant O
decrease O
in O
3TP B
activity O
as O
well O
as O
in O
vitro O
ERK B
kinase I
activity O
in O
CRAC O
. O

RVR B
' O
loss O
of O
function O
' O
studies O
by O
constitutive O
over O
- O
expression O
of O
a O
dominant O
negative O
RVR B
delta I
E I
resulted O
in O
increased O
levels O
of O
p21Cip1 B
/ O
Waf1 B
and O
myogenin B
mRNAs I
after O
serum O
withdrawal O
. O

Diagnosis O
of O
phenylalanine B
hydroxylase I
deficiency O
( O
phenylketonuria O
) O
. O

The O
PSS B
gene I
was O
subcloned O
into O
a O
1 O
. O
1 O
- O
kb O
fragment O
of O
the O
yeast O
DNA O
on O
the O
YEp13 O
vector O
. O

Collectively O
, O
this O
study O
emphasizes O
a O
critical O
role O
of O
Phox2a B
as O
well O
as O
its O
functional O
synergism O
with O
other O
transcription O
factors O
( O
e O
. O
g O
. O
, O
CREB B
, O
AP2 B
, O
and O
Sp1 B
) O
in O
transcriptional O
activation O
of O
the O
DBH B
gene I
. O

Blood O
from O
dams O
was O
collected O
prior O
to O
inoculation O
and O
at O
time O
of O
necropsy O
for O
measurement O
of O
IgM B
and O
IgG B
antibodies I
to O
M O
. O
pulmonis O
. O

Consistent O
with O
this O
model O
, O
a O
synthetic O
construct O
containing O
three O
tandem O
copies O
of O
the O
native O
LDL B
receptor I
SREBP B
site O
linked O
to O
a O
single O
Sp1 B
site I
was O
also O
significantly O
activated O
in O
a O
buttonhead B
- O
independent O
fashion O
. O

Consistent O
with O
this O
model O
, O
a O
synthetic O
construct O
containing O
three O
tandem O
copies O
of O
the O
native O
LDL B
receptor I
SREBP B
site O
linked O
to O
a O
single O
Sp1 B
site I
was O
also O
significantly O
activated O
in O
a O
buttonhead B
- O
independent O
fashion O
. O

Cyclin B
- I
dependent I
kinase I
- I
2 I
( O
Cdk2 B
) O
forms O
an O
inactive O
complex O
with O
cyclin B
D1 I
since O
Cdk2 B
associated O
with O
cyclin B
D1 I
is O
not O
phosphorylated O
by O
Cdk7 B
- O
cyclin B
- I
H I
. O

Cyclin B
- I
dependent I
kinase I
- I
2 I
( O
Cdk2 B
) O
forms O
an O
inactive O
complex O
with O
cyclin B
D1 I
since O
Cdk2 B
associated O
with O
cyclin B
D1 I
is O
not O
phosphorylated O
by O
Cdk7 B
- O
cyclin B
- I
H I
. O

According O
to O
the O
published O
sequence O
of O
the O
CHS1 B
gene I
, O
this O
fragment O
contains O
four O
repeats O
of O
a O
TGAAACA O
consensus O
sequence O
previously O
identified O
in O
the O
alpha B
- I
factor I
- O
inducible O
BAR1 B
promoter I
[ O
Kronstad O
, O
J O
. O

According O
to O
the O
published O
sequence O
of O
the O
CHS1 B
gene I
, O
this O
fragment O
contains O
four O
repeats O
of O
a O
TGAAACA O
consensus O
sequence O
previously O
identified O
in O
the O
alpha B
- I
factor I
- O
inducible O
BAR1 B
promoter I
[ O
Kronstad O
, O
J O
. O

Lysine B
- I
ketoglutarate I
reductase I
and O
saccharopine B
dehydrogenase I
from O
Arabidopsis O
thaliana O
: O
nucleotide O
sequence O
and O
characterization O
. O

SCID O
V B
( O
D B
) O
J B
recombination O
can O
be O
partly O
rescued O
in O
T O
- O
lymphocytes O
by O
either O
DNA O
- O
damaging O
agents O
( O
gamma O
- O
irradiation O
and O
bieomycin O
) O
or O
a O
null O
mutation O
of O
the O
p53 B
gene I
, O
possibly O
because O
of O
transiently O
elevated O
DNA O
repair O
activity O
in O
response O
to O
DNA O
damage O
or O
to O
delayed O
apoptosis O
in O
the O
absence O
of O
p53 B
. O

One O
P1 O
genomic O
clone O
and O
six O
subsequent O
plasmid O
subclones O
were O
isolated O
and O
analyzed O
for O
the O
exon O
- O
intron O
organization O
of O
the O
Ctpct B
gene I
. O

The O
activated O
glucocorticoid B
receptor I
forms O
a O
complex O
with O
Stat5 B
and O
enhances O
Stat5 B
- O
mediated O
transcriptional O
induction O
. O

The O
human B
ABCG1 I
gene I
encodes O
a O
member O
of O
the O
ATP B
- I
binding I
cassette I
( O
ABC B
) O
superfamily O
of O
transporter B
proteins I
and O
is O
highly O
induced O
when O
macrophages O
are O
incubated O
with O
oxysterols O
. O

Here O
we O
describe O
an O
in O
vitro O
assay O
where O
the O
NS3 B
- I
4A I
polyprotein I
, O
NS3 B
, O
the O
serine B
proteinase I
domain I
( I
the I
N I
- I
terminal I
181 I
residues I
of I
NS3 I
) I
, O
and O
the O
NS4A B
cofactor I
were O
produced O
by O
cell O
- O
free O
translation O
and O
tested O
for O
trans O
- O
processing O
of O
radiolabeled O
substrates O
. O

These O
results O
indicate O
that O
the O
PCNA B
gene I
is O
a O
likely O
target O
gene O
of O
E2F B
. O

Altogether O
these O
results O
suggest O
that O
, O
in O
KG1a O
cells O
, O
TNFalpha B
can O
stimulate O
in O
parallel O
PC B
- I
PLC I
and O
PLD B
, O
whose O
lipid O
products O
activate O
in O
turn O
mitogen B
- I
activated I
protein I
kinase I
( O
MAP B
kinase I
) O
and O
NF B
- I
kappaB I
signalling O
respectively O
. O

Interspecific O
backcross O
analysis O
using O
progeny O
derived O
from O
matings O
of O
( O
C57BL O
/ O
6J O
x O
Mus O
spretus O
) O
F1 O
x O
C57BL O
/ O
6J O
mice O
indicates O
that O
the O
thrombospondin B
gene I
is O
tightly O
linked O
to O
the O
Fshb B
, O
Actcl B
, O
Ltk B
, O
and O
B2M B
loci I
on O
murine O
chromosome O
2 O
. O

Interspecific O
backcross O
analysis O
using O
progeny O
derived O
from O
matings O
of O
( O
C57BL O
/ O
6J O
x O
Mus O
spretus O
) O
F1 O
x O
C57BL O
/ O
6J O
mice O
indicates O
that O
the O
thrombospondin B
gene I
is O
tightly O
linked O
to O
the O
Fshb B
, O
Actcl B
, O
Ltk B
, O
and O
B2M B
loci I
on O
murine O
chromosome O
2 O
. O

Surprisingly O
, O
Northern O
( O
RNA O
) O
blot O
analysis O
and O
reverse B
transcriptase I
- O
PCRs O
performed O
after O
transfection O
of O
COS O
- O
7 O
or O
HeLa O
cells O
with O
these O
viral O
RNAs O
revealed O
that O
Y88S B
and O
Y88L B
RNAs I
replicated O
at O
only O
very O
low O
levels O
. O

Surprisingly O
, O
Northern O
( O
RNA O
) O
blot O
analysis O
and O
reverse B
transcriptase I
- O
PCRs O
performed O
after O
transfection O
of O
COS O
- O
7 O
or O
HeLa O
cells O
with O
these O
viral O
RNAs O
revealed O
that O
Y88S B
and O
Y88L B
RNAs I
replicated O
at O
only O
very O
low O
levels O
. O

Deletion O
analyses O
implicate O
the O
N O
- O
terminal O
110 O
amino O
acids O
of O
Grb14 B
and O
ankyrin B
repeats O
10 O
- O
19 O
of O
tankyrase B
2 I
in O
mediating O
this O
interaction O
. O

The O
STAT B
- I
1 I
signaling O
pathway O
provides O
at O
least O
one O
mechanism O
for O
activation O
of O
the O
CAEV B
LTR I
by O
IFN B
- I
gamma I
in O
monocytes O
. O

By O
DNase B
I I
footprint O
analysis O
of O
the O
PNR O
element O
, O
a O
palindrome O
of O
two O
high O
- O
affinity O
Ets B
- I
binding I
sites I
( O
CTTCCCTGGAAG O
) O
was O
identified O
. O

Chloroplast B
mutator I
( O
chm B
) O
of O
Arabidopsis O
is O
a O
recessive O
nuclear O
mutation O
that O
causes O
green O
and O
white O
variegation O
in O
leaves O
and O
is O
inherited O
in O
a O
non O
- O
Mendelian O
fashion O
. O

Co O
- O
administration O
of O
5FU O
, O
angiotensin B
II I
and O
microspheres O
via O
the O
hepatic O
artery O
may O
reduce O
drug O
exposure O
in O
the O
systemic O
compartment O
and O
therefore O
may O
increase O
the O
therapeutic O
ratio O
of O
5FU O
administration O
via O
the O
hepatic O
artery O
. O

These O
results O
suggest O
that O
the O
c B
- I
met I
gene I
is O
also O
a O
target O
of O
p53 B
gene I
regulation O
. O

We O
describe O
the O
identification O
and O
initial O
characterization O
of O
neurobeachin B
, O
a O
neuron O
- O
specific O
multidomain O
protein O
of O
327 O
kDa O
with O
a O
high O
- O
affinity O
binding O
site O
( O
K O
( O
d O
) O
, O
10 O
nm O
) O
for O
the O
type B
II I
regulatory I
subunit I
of I
protein I
kinase I
A I
( O
PKA B
RII I
) O
. O

Two O
putative O
Rev B
proteins I
with O
apparent O
molecular O
masses O
of O
18 O
and O
16 O
kDa O
were O
expressed O
by O
p2 B
/ I
2 I
and O
p176 B
, O
while O
p20 B
expressed O
only O
a O
16 O
- O
kDa O
species O
. O

TaqMan O
analysis O
of O
gene O
expression O
following O
chronic O
FA O
treatment O
showed O
neither O
a O
decrease O
in O
the O
amount O
of O
leptin B
receptor I
( O
Ob B
- I
R I
) O
mRNA O
, O
nor O
an O
increase O
in O
the O
negative O
regulators O
of O
STAT B
signalling O
, O
SOCS3 B
( O
suppressors B
of I
cytokine I
signalling I
) O
or O
cytokine B
inducible I
sequence I
( O
CIS B
) O
. O

That O
sequence O
strongly O
promoted O
the O
transcription O
of O
the O
promotorless O
chloramphenicol B
acetyltranferase I
( O
CAT B
) O
gene O
in O
cells O
of O
pancreatic O
origin O
( O
AR O
- O
42J O
) O
but O
not O
in O
cells O
of O
non O
- O
pancreatic O
origin O
( O
Rat O
2 O
and O
IEC O
6 O
) O
. O

Fructokinase B
activity O
is O
elevated O
up O
to O
twofold O
when O
Z O
. O
mobilis O
was O
grown O
on O
fructose O
instead O
of O
glucose O
, O
and O
there O
was O
a O
parallel O
increase O
in O
frk B
mRNA I
levels O
. O

We O
have O
therefore O
evaluated O
the O
efficacy O
and O
safety O
of O
doxazosin O
, O
a O
new O
orally O
active O
selective O
alpha B
1 I
blocker O
, O
in O
patients O
with O
systemic O
hypertension O
with O
concomitant O
airflow O
limitation O
. O

Thus O
, O
the O
positive O
effect O
of O
NS1 B
on O
the O
steady O
- O
state O
levels O
of O
P4 B
transcripts I
depends O
on O
the O
amplification O
of O
gene O
copy O
number O
and O
the O
integrity O
of O
the O
terminal O
repeats O
. O

Anti B
- I
nucleolin I
mAb I
was O
used O
to O
confirm O
the O
antigenic O
properties O
of O
this O
p95 B
component I
. O

In O
light O
of O
the O
importance O
of O
GnRHR B
, O
the O
molecular O
mechanisms O
underlying O
the O
transcriptional O
regulation O
of O
the O
human B
GnRHR I
( O
hGnRHR B
) O
gene O
become O
a O
key O
issue O
in O
understanding O
human O
reproduction O
. O

Overexpression O
of O
Trdpm1 B
in O
a O
dpm1 B
( I
+ I
) I
: O
: O
his7 B
/ I
dpm1 I
( I
+ I
) I
S O
. O
pombe O
diploid O
resulted O
in O
a O
4 O
- O
fold O
increase O
in O
specific O
DPM B
synthase I
activity O
. O

This O
dynamic O
response O
strongly O
suggests O
that O
the O
p53 B
and O
Rb B
tumor O
suppressor O
pathways O
are O
intact O
in O
HeLa O
cells O
and O
that O
repression O
of O
HPV B
E6 I
and O
E7 B
mobilizes O
these O
pathways O
in O
an O
orderly O
fashion O
to O
deliver O
growth O
inhibitory O
signals O
to O
the O
cells O
. O

The O
Y O
. O
lipolytica O
genomic O
POT1 B
gene O
was O
disrupted O
by O
replacing O
120 O
bp O
of O
its O
coding O
sequence O
with O
2 O
. O
7 O
kbp O
of O
DNA O
including O
the O
Y O
. O
lipolytica O
LEU2 B
gene I
. O

Recent O
studies O
have O
demonstrated O
that O
the O
U1 B
snRNP I
is O
recruited O
to O
the O
5 O
' O
splice O
site O
by O
protein O
/ O
protein O
interactions O
involving O
the O
SR B
domains O
of O
the O
U1 B
- I
70K I
protein I
and O
SF2 B
/ O
ASF B
. O

D5 B
/ I
D1 I
( I
CT I
) I
or O
D5 B
/ I
D1D I
( I
CT I
) I
tail O
substitution O
mutants O
displayed O
a O
rank O
order O
of O
potency O
and O
agonist O
affinities O
virtually O
mimicking O
wild B
- I
type I
( I
wt I
) I
D1 I
receptors I
, O
as O
indexed O
by O
both O
ligand O
binding O
and O
dopamine O
- O
stimulated O
cAMP O
accumulation O
assays O
, O
and O
, O
similar O
to O
wt O
D1 B
receptors I
, O
did O
not O
exhibit O
receptor O
constitutive O
activity O
or O
responsiveness O
to O
inverse O
agonists O
. O

Using O
Southern O
blot O
analysis O
and O
restriction O
mapping O
of O
genomic O
YAC O
( O
yeast O
artificial O
chromosome O
) O
and O
cosmid O
clones O
, O
we O
located O
the O
human B
RIL I
gene I
240 O
- O
260 O
kb O
telomeric O
to O
the O
IRF1 B
gene I
and O
characterized O
its O
genomic O
structure O
. O

Transfection O
of O
non O
- O
deleted O
expression O
vector O
into O
NIH3T3 O
cells O
results O
in O
acquisition O
of O
focus O
- O
forming O
activity O
while O
a O
deleted O
form O
of O
expression O
vector O
fails O
to O
show O
this O
activity O
even O
in O
the O
presence O
of O
basic B
FGF I
. O

The O
effect O
of O
osmotic O
flow O
on O
the O
distribution O
of O
horseradish B
peroxidase I
within O
the O
intercellular O
spaces O
of O
toad O
bladder O
epithelium O
. O

Recombinant B
Ffh I
has O
a O
melting O
point O
of O
tm O
= O
89 O
degreesC O
. O

To O
better O
understand O
the O
role O
of O
Ets B
proteins I
in O
Ras B
transformation O
, O
we O
have O
now O
analyzed O
the O
effects O
of O
stably O
expressing O
a O
variety O
of O
Ets2 B
constructs I
in O
Ras B
- O
transformed O
NIH3T3 O
( O
DT O
) O
cells O
. O

To O
better O
understand O
the O
role O
of O
Ets B
proteins I
in O
Ras B
transformation O
, O
we O
have O
now O
analyzed O
the O
effects O
of O
stably O
expressing O
a O
variety O
of O
Ets2 B
constructs I
in O
Ras B
- O
transformed O
NIH3T3 O
( O
DT O
) O
cells O
. O

Also O
like O
the O
thrombin B
receptor I
, O
PAR2 B
can O
be O
activated O
by O
the O
hexapeptide O
corresponding O
to O
its O
tethered O
ligand O
sequence O
independent O
of O
receptor O
cleavage O
. O

In O
rlf2 B
mutants I
, O
telomeric O
chromatin O
is O
perturbed O
: O
Telomeric O
silencing O
is O
reduced O
and O
Rap1p B
localization O
is O
altered O
. O

The O
MXR B
gene I
encodes O
a O
half O
- O
transporter O
and O
the O
absence O
of O
cytogenetic O
evidence O
of O
coamplification O
of O
other O
regions O
suggests O
that O
a O
partner O
may O
not O
be O
overexpressed O
, O
and O
instead O
the O
MXR B
half I
- I
transporter I
homodimerizes O
to O
mediate O
drug O
transport O
. O

These O
kinases O
belong O
to O
a O
new O
subfamily O
related O
to O
the O
Trk B
subfamily I
. O

Taken O
together O
, O
these O
results O
demonstrate O
that O
the O
RP B
, O
like O
the O
20S B
proteasome I
, O
is O
functionally O
and O
structurally O
conserved O
among O
eukaryotes O
and O
indicate O
that O
the O
plant B
RPT I
subunits I
, O
like O
their O
yeast O
counterparts O
, O
have O
non O
- O
redundant O
functions O
. O

Solution O
structure O
and O
mechanism O
of O
the O
MutT B
pyrophosphohydrolase I
. O

NH2 O
- O
terminal O
trimming O
of O
Xenopus O
and O
mammalian B
FGF3s I
may O
therefore O
be O
a O
prerequisite O
of O
optimal O
biological O
activity O
. O

Immunohistochemical O
staining O
with O
MIB B
- I
1 I
and O
p53 B
antibodies I
showed O
low O
( O
< O
1 O
% O
) O
and O
negative O
reaction O
. O

Six O
of O
the O
gstC B
' I
mutants I
, O
primarily O
in O
the O
C O
- O
terminal O
half O
of O
C B
' I
, O
exhibited O
a O
defect O
in O
the O
ability O
to O
bind O
L B
protein I
. O

Six O
of O
the O
gstC B
' I
mutants I
, O
primarily O
in O
the O
C O
- O
terminal O
half O
of O
C B
' I
, O
exhibited O
a O
defect O
in O
the O
ability O
to O
bind O
L B
protein I
. O

MEKs B
and O
ERKs B
inhibited O
IL B
- I
6 I
activation O
of O
Stat3 B
harboring O
a O
mutation O
at O
serine O
- O
727 O
, O
the O
major O
site O
for O
serine O
phosphorylation O
, O
similar O
to O
inhibition O
of O
wild B
- I
type I
Stat3 I
, O
and O
inhibited O
Janus B
kinases I
Jak1 B
and O
Jak2 B
upstream O
of O
Stat3 B
in O
the O
Jak B
- O
STAT B
- O
signaling O
pathway O
. O

To O
identify O
additional O
non O
- O
Sir B
factors I
that O
affect O
rDNA O
silencing O
, O
we O
performed O
a O
genetic O
screen O
designed O
to O
isolate O
mutations O
which O
alter O
the O
expression O
of O
reporter O
genes O
integrated O
within O
the O
rDNA O
. O

S2F B
, O
a O
leaf O
- O
specific O
trans O
- O
acting O
factor O
, O
binds O
to O
a O
novel O
cis O
- O
acting O
element O
and O
differentially O
activates O
the O
RPL21 B
gene I
. O

Evidence O
from O
the O
structure O
of O
a O
number O
of O
cDNA O
clones O
, O
as O
well O
as O
S1 B
nuclease I
and O
primer O
extension O
studies O
supports O
the O
hypothesis O
that O
the O
PTHrP B
gene I
contains O
at O
least O
two O
mRNA O
transcription O
start O
points O
that O
define O
two O
putative O
regulatory O
domains O
. O

Evidence O
from O
the O
structure O
of O
a O
number O
of O
cDNA O
clones O
, O
as O
well O
as O
S1 B
nuclease I
and O
primer O
extension O
studies O
supports O
the O
hypothesis O
that O
the O
PTHrP B
gene I
contains O
at O
least O
two O
mRNA O
transcription O
start O
points O
that O
define O
two O
putative O
regulatory O
domains O
. O

The O
proteasome O
is O
a O
large O
complex O
consisting O
of O
two O
multisubunit O
structures O
, O
the O
20S B
and O
19S B
( O
PA700 B
) O
or O
P28 B
complexes I
, O
that O
combine O
to O
form O
the O
26S B
particles I
. O

The O
proteasome O
is O
a O
large O
complex O
consisting O
of O
two O
multisubunit O
structures O
, O
the O
20S B
and O
19S B
( O
PA700 B
) O
or O
P28 B
complexes I
, O
that O
combine O
to O
form O
the O
26S B
particles I
. O

All O
of O
the O
indigo O
- O
producing O
bacteria O
had O
an O
indoxyl B
phosphatase I
with O
a O
pI O
of O
6 O
. O
4 O
. O

Structure O
and O
expression O
of O
the O
alternative O
sigma B
factor I
, O
RpoN B
, O
in O
Rhodobacter O
capsulatus O
; O
physiological O
relevance O
of O
an O
autoactivated O
nifU2 B
- O
rpoN B
superoperon O
. O

Here O
we O
focused O
on O
the O
role O
of O
the O
5 O
' O
proximal O
regulatory O
cassette O
( O
- O
190 O
; O
+ O
53 O
bp O
) O
of O
the O
rat B
enkephalin I
( O
rENK B
) O
gene O
in O
the O
developmental O
regulation O
of O
the O
enkephalin B
phenotype O
. O

We O
obtained O
the O
prevalence O
of O
IgG B
antibodies I
against O
Trypanosoma O
cruzi O
among O
1076 O
blood O
donors O
at O
the O
Instituto O
Nacional O
de O
Cardiologia O
" O
Ignacio O
Chavez O
" O
in O
Mexico O
City O
. O

The O
NarX B
and O
NarQ B
proteins I
with O
amino O
acid O
substitutions O
at O
the O
first O
conserved O
histidine O
position O
were O
also O
unable O
to O
dephosphorylate O
NarL B
- O
phosphate O
in O
vitro O
. O

Regulation O
of O
Gax B
homeobox B
gene I
transcription O
by O
a O
combination O
of O
positive O
factors O
including O
myocyte B
- I
specific I
enhancer I
factor I
2 I
. O

The O
recognition O
specificity O
of O
the O
p55 B
PDZ B
domain I
appears O
to O
be O
unique O
, O
since O
the O
three O
PDZ B
domains I
of O
hDlg B
( O
human O
lymphocyte O
homologue O
of O
the O
Drosophila B
discs I
large I
tumor I
suppressor I
) O
do O
not O
bind O
the O
cytoplasmic O
domain O
of O
glycophorin B
C I
. O

The O
recognition O
specificity O
of O
the O
p55 B
PDZ B
domain I
appears O
to O
be O
unique O
, O
since O
the O
three O
PDZ B
domains I
of O
hDlg B
( O
human O
lymphocyte O
homologue O
of O
the O
Drosophila B
discs I
large I
tumor I
suppressor I
) O
do O
not O
bind O
the O
cytoplasmic O
domain O
of O
glycophorin B
C I
. O

The O
recognition O
specificity O
of O
the O
p55 B
PDZ B
domain I
appears O
to O
be O
unique O
, O
since O
the O
three O
PDZ B
domains I
of O
hDlg B
( O
human O
lymphocyte O
homologue O
of O
the O
Drosophila B
discs I
large I
tumor I
suppressor I
) O
do O
not O
bind O
the O
cytoplasmic O
domain O
of O
glycophorin B
C I
. O

Domain O
II O
is O
highly O
homologous O
to O
the O
LDL B
receptor I
and O
contains O
four O
repeats O
with O
perfect O
conservation O
of O
all O
6 O
consecutive O
cysteines O
. O

The O
Cdk2 B
- O
cyclin B
- I
D1 I
complex O
did O
not O
phosphorylate O
any O
tested O
substrates O
, O
such O
as O
H1 B
histone I
, O
pRB B
, O
SV40 B
large I
T I
antigen I
, O
p53 B
, O
E2F B
- I
1 I
or O
a O
preparation O
of O
nuclear O
proteins O
from O
HeLa O
cells O
; O
in O
contrast O
, O
Cdk2 B
- O
cyclin B
- I
E I
and O
Cdk2 B
- O
cyclin B
- I
A I
phosphorylated O
these O
proteins O
. O

The O
relatively O
mild O
defects O
observed O
in O
Rpd3 B
mutants I
suggest O
that O
the O
recently O
identified O
Groucho B
and O
dCtBP B
corepressor I
proteins I
do O
not O
function O
solely O
through O
the O
recruitment O
of O
histone B
deacetylases I
. O

The O
relatively O
mild O
defects O
observed O
in O
Rpd3 B
mutants I
suggest O
that O
the O
recently O
identified O
Groucho B
and O
dCtBP B
corepressor I
proteins I
do O
not O
function O
solely O
through O
the O
recruitment O
of O
histone B
deacetylases I
. O

These O
data O
further O
define O
a O
role O
for O
TRADD B
and O
TRAF2 B
in O
JNK B
activation O
and O
confirm O
that O
LMP1 B
utilizes O
signalling O
mechanisms O
used O
by O
the O
TNF B
receptor I
/ O
CD40 B
family O
to O
elicit O
its O
pleiotropic O
activities O
. O

daf B
- I
3 I
encodes O
a O
Smad B
protein I
that O
is O
most O
closely O
related O
to O
mammalian B
DPC4 I
, O
and O
is O
expressed O
throughout O
development O
in O
many O
of O
the O
tissues O
that O
are O
remodeled O
during O
dauer O
development O
. O

daf B
- I
3 I
encodes O
a O
Smad B
protein I
that O
is O
most O
closely O
related O
to O
mammalian B
DPC4 I
, O
and O
is O
expressed O
throughout O
development O
in O
many O
of O
the O
tissues O
that O
are O
remodeled O
during O
dauer O
development O
. O

The O
AtERF B
genes I
were O
differentially O
regulated O
by O
ethylene O
and O
by O
abiotic O
stress O
conditions O
, O
such O
as O
wounding O
, O
cold O
, O
high O
salinity O
, O
or O
drought O
, O
via O
ETHYLENE B
- I
INSENSITIVE2 I
( O
EIN2 B
) O
- O
dependent O
or O
- O
independent O
pathways O
. O

In O
vitro O
interaction O
studies O
, O
using O
proteins O
fused O
to O
glutathione B
- I
S I
- I
transferase I
, O
showed O
that O
RBP B
- I
J I
kappa I
and O
Su B
( I
H I
) I
bind O
directly O
to O
the O
RAM23 B
regions I
of O
mouse B
Notch1 I
and O
Drosophila B
Notch I
, O
respectively O
. O

In O
vitro O
interaction O
studies O
, O
using O
proteins O
fused O
to O
glutathione B
- I
S I
- I
transferase I
, O
showed O
that O
RBP B
- I
J I
kappa I
and O
Su B
( I
H I
) I
bind O
directly O
to O
the O
RAM23 B
regions I
of O
mouse B
Notch1 I
and O
Drosophila B
Notch I
, O
respectively O
. O

In O
vitro O
interaction O
studies O
, O
using O
proteins O
fused O
to O
glutathione B
- I
S I
- I
transferase I
, O
showed O
that O
RBP B
- I
J I
kappa I
and O
Su B
( I
H I
) I
bind O
directly O
to O
the O
RAM23 B
regions I
of O
mouse B
Notch1 I
and O
Drosophila B
Notch I
, O
respectively O
. O

Therefore O
, O
we O
conclude O
that O
DnaA B
may O
contact O
the O
beta O
subunit O
of O
RNA B
polymerase I
during O
activation O
of O
the O
pR B
promoter I
. O

Therefore O
, O
we O
conclude O
that O
DnaA B
may O
contact O
the O
beta O
subunit O
of O
RNA B
polymerase I
during O
activation O
of O
the O
pR B
promoter I
. O

It O
is O
present O
in O
the O
nucleus O
of O
the O
cells O
in O
which O
it O
is O
expressed O
and O
can O
phosphorylate O
and O
activate O
the O
cyclic B
AMP I
response I
element I
binding I
proteins I
CREB B
and O
CREM B
tau I
in O
a O
manner O
analogous O
to O
protein B
kinase I
A I
. O

These O
results O
demonstrate O
that O
a O
diverse O
set O
of O
carboxyl O
- O
terminal O
sequence O
motifs O
and O
posttranslational O
modifications O
lead O
to O
functional O
Ras B
proteins I
in O
yeast O
. O

The O
hBRAG B
gene I
was O
localized O
to O
the O
long O
arm O
of O
chromosome O
10 O
( O
10q26 O
) O
. O

During O
both O
encephalopathy O
episodes O
, O
CSF O
protein O
and O
immunoglobulin B
G I
( O
IgG B
) O
levels O
were O
elevated O
without O
an O
increased O
IgG B
index O
or O
IgG B
synthesis O
rate O
. O

The O
amino O
acid O
sequences O
of O
the O
predicted O
RfbA B
and O
RfbB B
homologs I
showed O
identities O
of O
75 O
. O
7 O
% O
( O
87 O
. O
9 O
% O
total O
similarity O
) O
and O
78 O
. O
0 O
% O
( O
86 O
. O
5 O
% O
total O
similarity O
) O
, O
respectively O
. O

Striking O
sequence O
similarities O
( O
57 O
and O
53 O
% O
) O
were O
observed O
with O
yeast O
mitochondrial O
proteins O
, O
SMF1 B
and O
SMF2 B
, O
especially O
within O
putative O
functional O
domains O
: O
exon O
6 O
encoding O
the O
second O
transmembrane O
spanning O
domain O
, O
site O
of O
the O
murine B
susceptibility I
mutation O
; O
and O
exon O
11 O
encoding O
a O
conserved O
transport O
motif O
. O

These O
data O
locate O
the O
aniridia B
gene I
( O
AN2 B
) O
and O
a O
recurrent O
T B
- I
cell I
leukemia I
breakpoint I
( O
TCL2 B
) O
in O
the O
marker O
sequence O
, O
on O
opposite O
sides O
of O
MIC1 B
. O

In O
contrast O
, O
over O
- O
expression O
of O
RAR B
beta I
only O
poorly O
restored O
differentiation O
, O
although O
it O
could O
replace O
RAR B
gamma I
for O
the O
activation O
of O
target O
genes O
. O

In O
contrast O
, O
over O
- O
expression O
of O
RAR B
beta I
only O
poorly O
restored O
differentiation O
, O
although O
it O
could O
replace O
RAR B
gamma I
for O
the O
activation O
of O
target O
genes O
. O

The O
coding O
sequences O
of O
the O
Crry B
gene I
encompass O
over O
25 O
kb O
of O
DNA O
, O
whereas O
the O
Crry B
- O
ps B
sequences O
are O
included O
within O
a O
single O
5 B
. I
6 I
- I
kb I
Eco I
- I
R1 I
fragment I
. O

Because O
the O
biosynthetic O
pathway O
to O
the O
vacuole O
intersects O
with O
the O
endocytic O
pathway O
, O
internalization O
of O
a O
bulk O
membrane O
endocytic O
marker O
FM O
4 O
- O
64 O
was O
assayed O
in O
the O
sop B
mutants I
. O

Significant O
alterations O
in O
CBC O
results O
and O
serum B
CRP I
concentration O
, O
compared O
with O
baseline O
values O
, O
were O
lacking O
in O
dogs O
of O
the O
control O
group O
. O

Cdk2 B
formed O
a O
complex O
with O
cyclin B
D1 I
in O
this O
system O
. O

Deletion O
analysis O
of O
rOC B
promoter I
- O
chloramphenicol B
acetyltransferase I
constructs O
demonstrates O
that O
an O
AML B
- I
1 I
- I
binding I
sequence I
within O
the O
proximal O
promoter O
( O
- O
138 O
to O
- O
130 O
nt O
) O
contributes O
to O
75 O
% O
of O
the O
level O
of O
osteocalcin B
gene I
expression O
. O

Deletion O
analysis O
of O
rOC B
promoter I
- O
chloramphenicol B
acetyltransferase I
constructs O
demonstrates O
that O
an O
AML B
- I
1 I
- I
binding I
sequence I
within O
the O
proximal O
promoter O
( O
- O
138 O
to O
- O
130 O
nt O
) O
contributes O
to O
75 O
% O
of O
the O
level O
of O
osteocalcin B
gene I
expression O
. O

Deletion O
analysis O
of O
rOC B
promoter I
- O
chloramphenicol B
acetyltransferase I
constructs O
demonstrates O
that O
an O
AML B
- I
1 I
- I
binding I
sequence I
within O
the O
proximal O
promoter O
( O
- O
138 O
to O
- O
130 O
nt O
) O
contributes O
to O
75 O
% O
of O
the O
level O
of O
osteocalcin B
gene I
expression O
. O

Recent O
studies O
using O
isolated O
rat O
adipocytes O
and O
chemically O
synthesized O
PIG O
compounds O
point O
to O
IRS1 B
/ I
3 I
tyrosine O
phosphorylation O
by O
p59Lyn B
kinase I
as O
the O
site O
of O
cross O
- O
talk O
, O
the O
negative O
regulation O
of O
which O
by O
interaction O
with O
caveolin B
is O
apparently O
abrogated O
by O
PIG O
. O

We O
have O
tested O
this O
proposal O
by O
carrying O
out O
circular O
dichroism O
( O
CD O
) O
and O
NMR O
experiments O
on O
the O
Skn B
domain I
and O
five O
truncated O
proteins O
. O

In O
addition O
, O
a O
noncanonical O
C B
/ I
EBP I
- I
binding I
site I
within O
the O
Gadd45gamma B
promoter I
where O
C B
/ I
EBPbeta I
and O
C B
/ I
EBPdelta I
could O
bind O
, O
was O
identified O
by O
electrophoretic O
mobility O
shift O
assay O
( O
EMSA O
) O
and O
reporter O
gene O
analysis O
. O

The O
strong O
conservation O
of O
the O
inverted O
terminal O
repeat O
sequence O
may O
reflect O
a O
common O
integration O
mechanism O
for O
VL30 B
elements I
and O
MuLV O
proviruses O
. O

In O
addition O
serum B
IgE I
concentrations O
were O
not O
statistically O
different O
. O

We O
have O
investigated O
the O
requirements O
of O
the O
CH B
gene I
switch O
by O
characterizing O
two O
rearranged B
gamma I
2b I
genes I
from O
a O
gamma B
2b I
producing O
mouse O
myeloma O
( O
MPC O
- O
11 O
) O
. O

We O
have O
investigated O
the O
requirements O
of O
the O
CH B
gene I
switch O
by O
characterizing O
two O
rearranged B
gamma I
2b I
genes I
from O
a O
gamma B
2b I
producing O
mouse O
myeloma O
( O
MPC O
- O
11 O
) O
. O

No O
such O
benefits O
were O
seen O
for O
children O
with O
CD4 B
+ I
counts O
below O
0 O
. O
2 O
x O
10 O
( O
9 O
) O
per O
liter O
at O
entry O
. O

We O
cloned O
the O
third O
human O
gene O
for O
the O
LD78 B
, O
termed O
LD78 B
gamma I
and O
the O
sequence O
analysis O
showed O
that O
it O
is O
a O
5 O
' O
- O
truncated O
pseudogene O
. O

Based O
on O
16S B
rRNA I
gene I
sequence I
analysis O
, O
the O
11 O
species O
having O
two O
tuf B
genes I
all O
have O
a O
common O
ancestor O
, O
while O
the O
six O
species O
having O
only O
one O
copy O
diverged O
from O
the O
enterococcal O
lineage O
before O
that O
common O
ancestor O
. O

Polypyrimidine O
and O
ssDNA O
binding O
by O
the O
isolated O
VH B
domain I
of O
immunization O
- O
induced O
anti O
- O
Z O
- O
DNA O
Ab O
resembles O
the O
activity O
of O
natural O
autoantibodies O
and O
suggests O
that O
VH B
- O
dependent O
binding O
to O
a O
ligand O
mimicked O
by O
polypyrimidines O
may O
play O
a O
role O
in O
B O
cell O
selection O
before O
immunization O
with O
Z O
- O
DNA O
. O

The O
pel B
gene I
from O
an O
Amycolata O
sp O
. O
encoding O
a O
pectate B
lyase I
( O
EC B
4 I
. I
2 I
. I
2 I
. I
2 I
) O
was O
isolated O
by O
activity O
screening O
a O
genomic O
DNA O
library O
in O
Streptomyces O
lividans O
TK24 O
. O

The O
pel B
gene I
from O
an O
Amycolata O
sp O
. O
encoding O
a O
pectate B
lyase I
( O
EC B
4 I
. I
2 I
. I
2 I
. I
2 I
) O
was O
isolated O
by O
activity O
screening O
a O
genomic O
DNA O
library O
in O
Streptomyces O
lividans O
TK24 O
. O

Treatment O
with O
oxyphenylbutazone O
and O
hydrocortisone O
failed O
to O
inhibit O
the O
raised O
serum B
CPN I
levels O
. O

In O
this O
study O
we O
provide O
evidence O
that O
B B
- I
Myb I
is O
a O
direct O
physiological O
target O
for O
cyclin B
A I
/ O
Cdk2 B
. O

mRNA O
for O
the O
HPV O
E6 B
/ O
E7 B
genes O
decreased O
; O
however O
, O
significant O
changes O
in O
the O
E7 B
protein I
were O
not O
observed O
, O
while O
increased O
levels O
of O
Rb B
immunoprecipitated O
with O
anti B
- I
E7 I
antibodies I
were O
observed O
. O

Acquired O
factor B
VIII I
inhibitor O
in O
non O
- O
hemophilic O
patients O

Transcript O
analysis O
reveals O
that O
lethal O
B B
block I
substitutions O
reduce O
U6 B
RNA I
synthesis O
at O
least O
10 O
- O
fold O
in O
vivo O
and O
20 O
- O
fold O
in O
vitro O
. O

Transcript O
analysis O
reveals O
that O
lethal O
B B
block I
substitutions O
reduce O
U6 B
RNA I
synthesis O
at O
least O
10 O
- O
fold O
in O
vivo O
and O
20 O
- O
fold O
in O
vitro O
. O

NF B
- I
kappaB I
is O
involved O
in O
the O
regulation O
of O
CD154 B
( O
CD40 B
ligand I
) O
expression O
in O
primary O
human O
T O
cells O
. O

Moreover O
, O
promoters O
containing O
a O
TATA O
box O
in O
the O
absence O
of O
Sp1 B
sites I
or O
Sp1 B
sites I
in O
the O
absence O
of O
a O
TATA O
box O
were O
equally O
inducible O
in O
vitro O
, O
as O
was O
an O
RNA B
polymerase I
III I
promoter I
. O

Moreover O
, O
promoters O
containing O
a O
TATA O
box O
in O
the O
absence O
of O
Sp1 B
sites I
or O
Sp1 B
sites I
in O
the O
absence O
of O
a O
TATA O
box O
were O
equally O
inducible O
in O
vitro O
, O
as O
was O
an O
RNA B
polymerase I
III I
promoter I
. O

Plasma B
renin I
activity O
does O
not O
predict O
the O
antihypertensive O
efficacy O
of O
chlorthalidone O
. O

We O
have O
cloned O
and O
sequenced O
the O
mouse B
NMO1 I
cDNA I
, O
which O
encodes O
the O
NAD B
( I
P I
) I
H I
: I
menadione I
oxidoreductase I
[ O
also O
called O
NAD B
( I
P I
) I
H I
: I
( I
quinone I
acceptor I
) I
oxidoreductase I
; O
quinone B
reductase I
; O
azo B
dye I
reductase I
; O
DT B
diaphorase I
; O
EC B
1 I
. I
6 I
. I
99 I
. I
2 I
] O
. O

We O
have O
cloned O
and O
sequenced O
the O
mouse B
NMO1 I
cDNA I
, O
which O
encodes O
the O
NAD B
( I
P I
) I
H I
: I
menadione I
oxidoreductase I
[ O
also O
called O
NAD B
( I
P I
) I
H I
: I
( I
quinone I
acceptor I
) I
oxidoreductase I
; O
quinone B
reductase I
; O
azo B
dye I
reductase I
; O
DT B
diaphorase I
; O
EC B
1 I
. I
6 I
. I
99 I
. I
2 I
] O
. O

As O
expected O
for O
a O
positive O
SpHE B
transcriptional I
regulator I
, O
the O
timing O
of O
SpEts4 B
gene I
expression O
precedes O
the O
transient O
expression O
of O
SpHE B
in O
the O
very O
early O
sea O
urchin O
blastula O
. O

The O
sequence O
of O
the O
HIR1 B
gene I
predicts O
an O
88 O
- O
kDa O
protein O
with O
three O
repeats O
of O
a O
motif O
found O
in O
the O
G B
beta I
subunit I
of O
retinal B
transducin I
and O
in O
a O
yeast O
transcriptional O
repressor O
, O
Tup1 B
. O

The O
sequence O
of O
the O
HIR1 B
gene I
predicts O
an O
88 O
- O
kDa O
protein O
with O
three O
repeats O
of O
a O
motif O
found O
in O
the O
G B
beta I
subunit I
of O
retinal B
transducin I
and O
in O
a O
yeast O
transcriptional O
repressor O
, O
Tup1 B
. O

